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SUMMARY 
Hematopoietic stem cells (HSCs) are responsible for life-long production of all 
mature blood cells. This unique characteristic makes them an ideal candidate for cell-
based therapies to treat various hematological malignancies. Their extensive use in the 
clinic is often hampered due to insufficient number of cells obtained from donors. 
Countless attempts to expand HSCs in vitro have failed, primarily due to our inability 
to recapitulate key features of the native bone marrow microenvironment, termed 
niche, in a dish. The absence of important niche signals in vitro results in rapid 
proliferation of HSCs with a concomitant loss of their long-term multi lineage blood 
reconstitution potential. The niche in the bone marrow involves a highly complex 
network of physical and biochemical signals that, in concert with cell-intrinsic 
mechanisms, is believed to control HSC fate choices. Moreover, the hypoxic 
conditions in the niche present an extreme metabolic environment, imposing HSCs to 
attain a distinct metabolic identity as compared to their differentiated progeny. 
However, despite decades of research and new insights on HSC niche composition 
and their metabolic regulation, it is currently very poorly understood how HSCs take 
the decision to either undergo self-renewal or differentiation. Insights into the 
mechanisms regulating HSC fate choices are key to design better strategies for HSC 
maintenance and expansion in vitro for use in clinical transplantation. 
 
The overall goal of this thesis is to employ innovative experimental tools to explore 
the role of metabolism in regulating HSC fate choices. In the first part of this thesis a 
versatile cell-tracking assay was developed to follow HSC divisions in vitro. A 
combination of cell tracking and immunostaining was used to systematically map 
phenotypic changes in HSCs up to four divisions, under defined culture conditions 
imposing specific fates. Our preliminary analysis showed that the proportion of cells 
maintaining an HSC phenotype decreased with increasing number of cell divisions, 
supporting the notion that faster cycling results in HSC exhaustion. 
 
In the second part of this thesis, we for the first time identify a causative link between 
mitochondrial metabolism and HSC fate decision. Using flow cytometry and long-
term blood reconstitution assays, low mitochondrial activity was established as a 
reliable marker of functional HSCs, independent of their cell cycle state. 
Consequently, we could use this marker to reliably identify self-renewing HSCs from 
heterogeneous in vitro cultures. Strikingly, we found that HSC fate could be altered 
by artificially modulating their mitochondrial activity in vitro. These results suggest 
that mitochondrial activity is a determinant of HSC fate. 
 
The last part of this thesis describes an experimental paradigm to analyze in vivo 
niche-instructed fate choices in paired HSC daughter cells. Live single cell imaging 
revealed a significant increase in asynchronous divisions in niche activated HSCs 
compared to control cells, suggesting a possible involvement of niche-instructed 
asymmetric cell division program. Indeed, a significantly higher level of asymmetric 
?? ??
gene expression was found in paired daughter cells arising from niche-instructed 
HSCs. This analysis led to the identification of 12 asymmetrically expressed genes, 
among them were key enzymes belonging to glycolytic and mitochondrial TCA cycle 
metabolic pathways. 
 
Altogether, this thesis successfully employed unique experimental strategies to 
provide an intriguing link between metabolism and HSC fate choices. As many adult 
stem cell populations reside in similar metabolic microenvironments this knowledge 
can potentially be used to identify and study stem cells from other systems. 
 
Keywords: asymmetric cell division (ACD), cell tracking, differentiation, 
hematopoietic stem cells (HSCs), niche, metabolic regulation, microenvironment, 
mitochondrial activity, paired daughter cells (PDCs), self-renewal, single cell 
analysis, stem cell fate, transplantation  
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RÉSUMÉ 
Les cellules souches hématopoïétiques (CSHs) sont à l’origine de toutes les cellules 
sanguines matures, assurant ainsi la régénération du sang durant toute la vie d’un être 
humain. Grâce à cette particularité unique, ces cellules sont considérées comme des 
candidates idéales pour la thérapie cellulaire afin de soigner les différentes maladies 
sanguines. Cependant, l’utilisation systématique des CSHs en clinique est limitée par 
leur faible nombre, principalement à cause de l’insuffisance de donation et de 
l’inefficacité des méthodes d’expansion des ces cellules in-vitro. En effet, les 
méthodes d’expansion actuelles, souvent basées sur l’utilisation de boîtes de Petri, 
reproduisent pauvrement l’environnement spécifique de la moelle osseuse, aussi 
appelé « niche ». L’absence des signaux biologiques importants in vitro rapidement 
induit les CSHs à proliférer rapidement et perdre leur potentiel à produire les 
multiples lignées descendantes sur le long terme. Un réseau complexe de signaux 
physiques, chimiques et métaboliques régule le choix du devenir des CSHs. De plus, 
l’hypoxie de la niche représente un environnement métabolique extrême permettant 
aux CSHs de maintenir une identité métabolique unique et différente de leur 
descendance. Ainsi, la compréhension des mécanismes qui contrôlent le devenir des 
CSHs est la clé de la standardisation des transplantations de CSHs artificiellement 
générées in vitro.  
L’objectif de ce travail de doctorat est de comprendre la relation en la régulation 
métabolique et le choix du devenir des CSHs en utilisant des techniques 
expérimentales innovatives. Dans la première partie de cette étude, nous avons mis en 
place une méthode de surveillance de cellules permettant de suivre en temps réel la 
division cellulaire des CSHs in vitro. Ainsi, nous avons pu suivre au moins cinq 
divisions successives et comprendre la dynamique de la division cellulaire sous 
différentes conditions de culture. De plus, nous avons pu observer que la fraction des 
cellules qui conservent le phénotype des CSHs est petite dans la population qui se 
multiplie rapidement comparé à leurs homologues se divisant lentement. Dans la 
deuxième partie, nous identifions pour la première fois le lien entre l’activité 
mitochondriale et le choix du devenir des CSHs. En utilisant la cytométrie en flux, et 
l’analyse de la reconstitution sanguine à long terme, nous avons défini qu’une faible 
activité mitochondriale apparaît comme une marque fiable pour identifier les CSHs 
fonctionnelles dans la moelle osseuse.  En particulier, ce caractère peut être utilisé 
pour identifier et isoler les CSHs ayant la capacité de s’auto-renouveler à partir d’une 
population cultivée in vitro, souvent très hétérogène. De plus, nous avons réussi à 
moduler le comportement des CSHs en artificiellement altérant leur activité 
mitochondriale in vitro. Ensemble, ces données indiquent une relation de causalité 
importante entre l’activité mitochondriale et la décision du devenir des CSHs.  
La dernière partie de cette étude se focalise sur l’élucidation des signaux impliqués 
dans la régulation d’un phénomène important de la biologie des CSHs, à savoir la 
division cellulaire asymétrique (DCA). Nous avons mis en place un paradigme 
expérimental unique qui combine les techniques d’imagerie des cellules vivantes et 
d’analyse d’expression génétique à l’échelle des cellules individuelles. Ceci a permis 
l’identification de gênes clés impliqués dans le métabolisme qui sont exprimés 
différemment entre les deux cellules filles, suggérant leur rôle indispensable dans la 
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DCA. Spécifiquement, les cellules maintenues in vivo présentent présentent un haut 
niveau d’asymétrie dans l’expression génique comparées à leur homologues générés 
in vitro, confirmant encore le rôle critique de la niche dans le control du 
comportement des CSHs dans la DCA. 
Cette étude révèle de nouveaux médiateurs métaboliques contrôlant le choix du 
devenir des CSHs. Une meilleure compréhension dans la régulation des CSHs va 
contribuer à la mise en place des nouvelles stratégies pour conserver et amplifier les 
CSHs in vitro en vue de leur transplantation. De plus, étant donné que la majorité des 
cellules souches adultes se trouvent dans des microenvironnements métaboliques 
similaires, nous suggérons que ces résultats peuvent être utiles pour identifier et 
étudier les cellules souches dans d’autres tissus.  
 
Mots clés : division cellulaire asymétrique (DCA), suivi des cellules, cellule souche 
hématopoïétique (CSH), niche in vivo, régulation métabolique, micro-environnement, 
activité mitochondriale, auto-renouvellement, expression génique de cellule 
individuelle, devenir de cellule souche, transplantation  
  
?? ????
सारांश 
िहमेटोपोयिटक?से्टम?कोिशकाओं??हसक??सभी?रक्त?कोिशकाओं?के?जीवन?भर?के?उत्पादन?के?िलए?उत्तरदायी?हैं ।?यह?
िवशेष गुण?उन्हें ? िविभन्न? िहमेटोलोिजकल?कैं सर?के?इलाज?के? िलए?और सेल?आधािरत? िचिकत्सा?के? िलए?एक?आदशर् ?
उम्मीदवार?बनाता?है।?िक्लिनक?में ?उनका?व्यापक?उपयोग?अक्सर?दानदाताओं?से?प्राप्त?कोिशकाओं?की?अपयार्प्त?संख्या?
के?आड़े?आती? है।? परनु्त इनमें  एक कमी है िक इन हसक को प्रयोगशाला में  उत्पन नही िकया जा सकता क्योंिक 
प्रयोगशाला की पिरिस्थितयाँ इन हसक की अिस्थ?मज्जा की पिरिस्थितयों से अलग है। इसके अलावा अिस्थ मज्जा में  
ऑक्सीजन की कमी होने के कारण हसक एक अलग metabolic पहचान प्राप्त कर लेते हैं । परनु्त यह 
metabolic पहचान कैसे हसक को िविनयिमत करती है िक वो और अिधक हसक बनाये या िफर और रक्त 
कोिशका बनाये (fate choice), अनेक दश्कों की खोज इस प्रिक्रया को समझ नही पायी है।?
?
इस?थीिसस?का? मुख्य? उदेश्य? है? हसक?का? नई? तरह? के? प्रयोिगक? उपकरण? के? रुप?में ? उपयोग?करना? िजनमें ? उनके?
metabolism को? िनयंित्रत?करके?ऊपर? िलखी?प्रिक्रया?को? बेहतर समझना। थीिसस के प्रथाम भाग में  हसक के 
िवभाजन पर नजर रखने का एक नया तरीका िवकिसत िकया गया जो हसक के िवभागों का प्रयोगशाला में  
अनुसरण कर सके। इस तरीके को हमने immunostaining के साथ जोड़ के यह प्रमािणत िकया िक अगर 
हसक तेज़ी से िवभािजत होते हैं  तो उनका phenotype जल्दी नष्ट हो जता है। 
?
थीिसस?के?िद्वतीय?भाग?में ?हुमने?पहली?बार?माइटोकॉिन्ड्र यल?metabolism?और?हसक?की?fate choice?के?बीच?
सम्बन्ध?पाया। इस सम्बन्ध को स्थािपत करने के िलए flow cytometry और रख्त बनाने की शमता का उपयोग 
िकया, तथा कम माइटोकॉिन्ड्र यल गितिविध की हसक के िवशवसनीय marker के रुप में  पहचान हुई। साथ ही 
हमने यह पाया िक अगर माइटोकॉिन्ड्र या की गितिविध बदली जये तो हसक का भाग्य (fate choice) कुछ हद 
तक बदला जा सकता है। पिरणामतः माइटोकॉिन्ड्र यल गितिविध हसक के भाग्य का एक महत्वपूणर्  िनधार्रक है।?
?
थीिसस?के?अिन्तम?भाग?में ?हमने?अिस्थ?मज्जा?में ?तयार?हसक?के? िवभाजन?के?बाद?उत्पन?होने?वाली?कोिशकाओं?को?
प्रयोगशाला?में ?समझने?का?प्रयतन?िकया। Gene expression के माध्यम से हमने बारह ऎसे genes की पेहचन 
करी जो हसक के िवभाजन के बाद उत्पन होने वाली कोिशकाओं में  अलग स्तर पर व्यकत होती हैं । इन में  से कयी 
genes glycolytic और माइटोकॉिन्ड्र यल TCA cycle enzymes की हैं ।  
 
कुल िमलाकर इस metabolism और हसक fate choice के मध्य सम्बन्ध का ज्ञान अन्य से्टम कोिशकाओं 
का भी अध्ययन कर सकते हैं । 
?
कीवडर् ?? िहमेटोपोयिटक? से्टम? कोिशकाओं? ?हसक??? अिस्थ? मज्जा, metabolic पहचान, कोिशका? िवभाजन, 
माइटोकॉिन्ड्र यल?गितिविध??हसक fate choice 
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Motivation 
A hallmark of adult stem cells is their ability to maintain and to some extent 
regenerate a particular tissue throughout the life of the organism. This unique trait 
makes them ideal for cell-based therapies to treat many life-threatening diseases. The 
hematopoietic system, responsible for life-long blood production, has one of the best 
characterized adult stem cell populations. With more than 30,000 bone marrow 
transplantations being carried out every year in Europe alone, hematopoietic stem 
cells (HSCs) hold immense potential in the clinic (Passweg et al., 2014). Although the 
number of transplants being performed has gone up consistently over the past few 
decades (Tan et al., 2007), the widespread clinical use of HSCs is often limited by the 
amount of cells obtained from donors. Even though bone marrow and peripheral 
blood are the primary sources of HSCs isolated from donors today (Passweg et al., 
2013), umbilical cord blood (UCB) has become an attractive source of HSCs in recent 
years, due to its widespread availability, non-invasive collection and easy long-term 
cryo preservation (Ballen et al., 2013). However, due to low cell numbers, UCB use 
has been restricted to pediatric patients; double cord blood transplantation did not 
show encouraging survival rates in adult patients (Ballen et al., 2013). 
 
Expansion of HSCs in vitro therefore holds great potential and will allow overcoming 
limitations due to low cell number. However, despite several decades of research, a 
reliable clinically approved in vitro culture method does not exist for expanding HSCs 
without a concomitant loss of their multi‐potential capacity (Walasek et al., 2012). 
Moreover, in vitro culture of purified HSCs results in an extremely heterogeneous 
population of cells, consisting primarily of progenitors, after few rounds of division. 
Additionally, post in vitro culture, the cell surface marker repertoire does not reliably 
identify functional HSCs, hindering their isolation from these heterogeneous 
populations (Dorrell et al., 2000).  
 
The rapid loss of HSC multi-potency in culture is primarily due to our inability to 
fully recapitulate the complex HSC microenvironment, termed niche, in an in vitro 
culture setting. Indeed, the in vivo niche, instrumental in regulating HSC fate choices, 
presents a complex cocktail of chemical, physical and metabolic cues to ensure life 
long HSC maintenance and, therefore, blood production (Lutolf and Blau, 2009; 
Morrison and Spradling, 2008; Nakamura-Ishizu and Suda, 2013; Wang and Wagers, 
2011; Wilson and Trumpp, 2006). Importantly, the hypoxic state of the niche exposes 
HSCs to an extreme metabolic environment that is believed to impose a unique 
metabolic identity as compared to their differentiated progeny (Ito and Suda, 2014; 
Suda et al., 2011; Zhang and Sadek, 2014). 
 
Therefore, the maintenance and expansion of HSCs in vitro without genetic 
manipulation would constitute a major advance in bone marrow regenerative 
medicine. To successfully overcome this obstacle, a better understanding of the 
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mechanisms that control HSC fate and, in particular the choice of the cell to self-
renew or differentiate is crucial. 
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Objectives and Overview 
The overall goal of this thesis is to employ innovative experimental tools to explore 
the role of metabolism in regulating HSC fate choices. Mus musculus is used as an 
experimental model system, as it provides powerful tools for HSC isolation from the 
bone marrow and for performing in vivo functional assays to assess long-term HSC 
function. 
 
Chapter 1 of this thesis summarizes the current knowledge of the hematopoietic 
system, focusing primarily on the HSC niche and its role in regulating HSC fate 
choices.   
 
Chapter 2 describes the development of a cell-tracking assay to follow divisional 
dynamics of HSCs in various in vitro culture conditions. Combining HSC surface 
marker analyses with division tracking allowed precise estimation of progeny 
retaining HSC phenotype in different divisional states.  
 
In Chapter 3 of the thesis, the role of mitochondrial activity in determining HSC fate 
decisions is explored. Using flow cytometry analysis and long-term in vivo blood 
reconstitution assays, we establish low mitochondrial activity as a reliable marker to 
identify functional HSCs from the bone marrow and, from heterogeneous in vitro 
cultures. Intriguingly, we could alter HSC fate by artificially modulating 
mitochondrial activity, suggesting that the metabolic state is a key determinant of 
HSC fate choices. 
 
Chapter 4 presents a novel experimental paradigm to analyze the disparate cell fates 
in paired HSC daughters. Live-cell imaging combined with single-cell gene 
expression analysis performed on paired daughter cells arising from in vivo-instructed 
HSCs led to the identification of a set of asymmetrically expressed genes. This set 
included some key metabolic genes involved in glycolysis and mitochondrial TCA 
cycle. Moreover, in vivo-instructed cells showed higher levels of asymmetric gene 
expression, suggesting execution of niche instructed asymmetric fate choice program. 
 
Chapter 5 summarizes the work described in this thesis and discusses its relevance in 
our current understanding of the hematopoietic system. 
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Background 
Hematopoietic stem cells 
The bone marrow hematopoietic stem cells (HSCs) are crucial for lifelong production 
of all mature blood cells. They are characterized by their dual ability to 
simultaneously generate identical copies of themselves (self-renewal) and give rise to 
differentiated progeny (commitment) to replenish the blood system (Figure 1.1). 
Although the majority of HSCs are present in the quiescent cell cycle state (Cheshier 
et al., 1999; Wilson et al., 2008) the rapid turnover of blood production is ensured by 
highly proliferative transient progenitors downstream of HSCs that lack self-renewal 
ability yet possess full lineage differentiation potential (Morrison and Weissman, 
1994). These multi potent progenitors (MPPs) produce mature blood cells via a multi-
step commitment process by first giving rise to lineage restricted progenitors that 
further divide to produce only one mature cell type (Christensen and Weissman, 
2001). Hematopoiesis occurs in anatomically distinct locations through mammalian 
development. Before birth HSCs are present in the fetal liver and the spleen, making 
them the major sites for hematopoiesis. Eventually, hematopoiesis shifts primarily to 
the bone marrow, where blood formation is maintained throughout postnatal life 
(Wang and Wagers, 2011).  
 
Classically, adult HSCs were identified by their ability to efflux the Hoechst dye 
through membrane transport pumps and were shown to be enriched in the “side 
population” from the bone marrow (Goodell et al., 1996). Recent advances in the field 
have allowed for the use of cell surface markers for the identification and isolation of 
HSCs by flow cytometry. They were initially shown to be contained in the Lin- cKit+ 
Sca1+ (LKS) population from the bone marrow, which was identified by negative 
selection for markers for mature hematopoietic cell lineages (Lin-) and positive 
selection for the cKit and Sca1 cell surface markers (Okada et al., 1992). Further 
enrichment of the HSC population was achieved with the use of CD34 negativity 
(Osawa et al., 1996). However, long-term blood reconstitution assays demonstrated 
that only 30-50% of the LKS CD34- cells had stem potential (Osawa et al., 1996). 
Further purification of the HSC fraction could be achieved by the differential 
expression of the signaling lymphocyte activation molecule (SLAM) markers, CD150 
and CD48 (Kiel et al., 2005). Combining these different strategies the most 
commonly used combination of markers to identify an extremely purified HSC 
population is LKS CD150+ CD48- CD34- (Wilson et al., 2007). Moreover, early 
progenitors in the hematopoietic hierarchy could be identified by up-regulation of 
CD34 and CD48, followed by down regulation of CD150 (Wilson et al., 2007). 
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Figure 1.1: The hematopoietic hierarchy. HSCs at top of the hierarchy have a dual role of self-
renewal and commitment, ensuring life long blood production. CAR:CXCL12-abundant reticular cells, 
ECM: Extracellular matrix, MSC: Mesenchymal stem cells, MPP: Multi potent progenitor, CMP: 
Common myeloid progenitor, GMLP: Granulocyte-macrophage-lymphoid progenitor, MEP: 
Megakaryocyte-erythrocyte progenitor, GMP: Granulocyte-macrophage progenitor, CLP: Common 
lymphoid progenitor. Image from (Rossi et al., 2012). 
 
Hematopoietic stem cell niche 
The concept of the HSC “Niche” was first proposed by Schofield, at that time it was 
believed that the HSCs associate with other cells in the bone marrow (BM) capable of 
determining their behavior (Schofield, 1978). Moreover, this association was 
hypothesized to be critical for the maintenance of HSC stemness. The first evidence 
of the existence of the niche came from investigation of two mutant mouse strains (W 
strain and Sl strain) that showed severe anemia and lack of mast cell production 
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(Bernstein et al., 1968; Geissler and Russell, 1983; Kitamura and Go, 1979; Kitamura 
et al., 1978). When normal BM cells were transplanted into W mutant mice, 
hematopoiesis was restored, whereas transplanting normal BM cells into Sl mutant 
mice did not result in normal hematopoiesis. When W mutant BM was transplanted in 
either WT or Sl mice it did not show normal hematopoiesis. However, when Sl 
mutant BM was transplanted in W mutant mice hematopoiesis was restored. The 
outcomes of these transplants could be explained by concluding that the W locus was 
essential for functional HSCs while the Sl locus was an essential environmental 
component for hematopoiesis but was not present on HSCs (Jarboe and Huff, 1989; 
Mayer and Green, 1968; Russell and Bernstein, 1968). The W gene was later found to 
be cKit (Nocka et al., 1989; Reith et al., 1990), an essential cell surface receptor 
present on all HSCs, while the Sl gene was identified as Stem cell factor (SCF), the 
ligand for cKit (Zsebo et al., 1990) expressed by the niche cells. The idea of the niche 
has evolved ever since; it now includes various cell types in distinct anatomical 
locations, secreted cytokines, soluble factors, oxygen concentration and many other 
physical parameters (Figure 1.2) (Lutolf and Blau, 2009). 
 
 
 
 
Figure 1.2: The hematopoietic stem cell niche.  Various cellular as well as acellular components 
form the hematopoietic niche. Image from (Wang and Wagers, 2011). 
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The osteoblasts are one of the best-characterized niche cells. Interaction of the 
osteoblasts and HSCs at the interface of the bone and the marrow space forms the 
endosteal niche (Figure 1.3). Using transgenic mice it was shown that increase in 
osteoblast number resulted in an expanded HSC population (Calvi et al., 2003), 
whereas osteoblast ablation led to loss of the HSC pool (Visnjic et al., 2001; Visnjic 
et al., 2004). Moreover, in vitro studies demonstrated that long term reconstitution 
potential of HSCs could be maintained when co-cultured with osteoblasts (Chitteti et 
al., 2010; Nakamura et al., 2010; Taichman et al., 1996). Additionally, osteoblasts 
were shown to be the source of some key factors regulating HSC maintenance and
survival; these include angiopoietin, N-cadherin, thrombopoietin, osteopontin, Wnt, 
and Notch (Arai et al., 2004; Fleming et al., 2008; Haug et al., 2008; Hosokawa et al., 
2010a; Hosokawa et al., 2010b; Morrison and Spradling, 2008; Qian et al., 2007; Stier 
et al., 2005). Recent studies using high resolution in vivo imaging techniques have 
demonstrated close physical association of HSCs with osteoblasts (Kohler et al., 
2009; Lo Celso et al., 2009; Takaku et al., 2010; Xie et al., 2009). Interestingly, 
progenitor cells were not seen in close proximity with the osteoblasts in these studies, 
suggesting that the interaction is specific to the HSC population.  
 
 
 
Figure 1.3: Interactions between HSCs and the niche cells. Image from (Trumpp et al., 2010). 
 
In addition to the osteoblasts, HSCs were found in close association with the bone 
marrow sinusoids suggesting the existence of a perivascular niche (Kiel et al., 2005). 
Proximity to the vasculature is believed to act as a gateway for the HSCs transiting 
into or out of the bloodstream. Moreover, it might also be important in sensing 
systemic signals from the body and therefore regulate blood cell production. Various 
cell types in the perivascular space were shown to regulate HSC function; these 
include MSCs, CXCL12-adundant reticular  (CAR) cells, endothelial cells and neural 
cells. Ablation of nestin positive MSCs resulted in a dramatic reduction of the HSC 
population (Mendez-Ferrer et al., 2010). Moreover, deletion of Cxcl12 expressing 
CAR cells resulted in 50% reduction in HSC numbers without any effect on the MPP 
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population (Omatsu et al., 2010). Interestingly, HSC population from CAR depleted 
mice was seen to be more quiescent (Omatsu et al., 2010). Additionally, conditional 
knock out of SCF in endothelial cells was shown to result in reduction in HSC 
numbers (Ding et al., 2012). However, all these cell types were identified using non-
overlapping markers and it is possible that some of these marker systems identify 
overlapping populations. Intriguingly, components of the nervous system have also 
been implicated as an important part of the niche, non-myelinating Schwann cells 
were shown to sustain the HSC pool through TGF-β signaling (Yamazaki et al., 
2011).  
 
Apart from various cell types one of the most important characteristic of the niche is 
that it is extremely hypoxic. Staining with pimonidazole, a chemical marker for 
hypoxia revealed that HSCs are indeed hypoxic (Parmar et al., 2007). As a result, 
hypoxia inducible factor (HIF1α) was found to be highly upregulated in HSCs 
(Takubo et al., 2010). Recent work using live in vivo imaging of oxygen concentration 
using phosphorescence lifetime sensing nanoprobes revealed that the oxygen levels in 
the BM were significantly lower as compared to the cortical bone (Spencer et al., 
2014). Together the cellular and acellular components of the niche are believed to 
regulate the HSC fate via a complex interplay of different signaling pathways (Lutolf 
and Blau, 2009; Morrison and Spradling, 2008; Nakamura-Ishizu and Suda, 2013; 
Suda et al., 2011; Wang and Wagers, 2011; Wilson and Trumpp, 2006). 
 
Hematopoietic stem cell fate choices 
Maintenance of the HSC pool and simultaneous production of committed progeny is 
essential for lifelong blood production. A fine balance of different HSC fate choices is 
crucial to successfully carry out both these objectives (Figure 1.4). Moreover, when 
the organism is under hematopoietic stress such as extreme blood loss or infection, 
this balance needs to be carefully adjusted to achieve the same outcomes. Therefore, 
the fate that an HSC chooses (or is instructed) to undertake must be tightly regulated.  
 
Symmetric expansion divisions were shown to be most relevant during embryonic or 
fetal development in multiple systems. Since these developmental stages are 
associated with massive growth and increase in cell number, it is quite intuitive that 
the stem cell pool would also expand. The mouse hematopoietic stem cells were 
found to double every 24 hours during mid gestation (Morrison et al., 1995), 
suggesting that atleast some of the HSCs underwent symmetric expansion divisions. 
Moreover, imaging studies during embryonic development of mouse cerebral cortex 
and the epidermis, showed a rapid expansion of undifferentiated pool of cells before 
the differentiated progeny arises (Huttner et al., 2005; Lechler and Fuchs, 2005; 
Noctor et al., 2004). However, in adults, symmetric expansion divisions were 
observed to restore stem cell pools depleted after injury. In the hematopoietic system, 
granulocyte-colony stimulating factor (G-CSF) mediated mobilization of HSCs from 
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the bone marrow led to rapid proliferation and expansion of the HSC pool (Bodine et 
al., 1996; Morrison et al., 1997; Wright et al., 2001). 
 
Asymmetric cell division results in the generation of two daughters with different 
stem potential (self-renewal). Under homeostasis, this fate choice presents an 
attractive strategy to maintain the HSC pool and produce differentiated progeny at the 
same time. Classical studies in Drosophila and C. Elegans have implicated both 
intrinsic (mediated by PAR family of proteins) (Doe and Bowerman, 2001; Strome 
and Wood, 1983) and extrinsic mechanisms (Yamashita et al., 2005) in mediating 
asymmetric cell division. In the hematopoietic system, pair daughter cell analysis 
revealed different colony forming potential (Takano et al., 2004) and in vivo 
reconstitution ability (Ema et al., 2000; Yamamoto et al., 2013) suggesting HSCs 
carry out asymmetric divisions. However, compelling evidence and mechanistic 
understanding of asymmetric division in adult HSCs is currently lacking.  
 
  
 
Figure 1.4: Hematopoietic stem cell fate choices.  Different fate choices that an HSC can undertake. 
Fate choices are finely regulated by extrinsic signals from the niche and intracellular mechanisms in 
HSCs. 
 
Despite immense self-renewing potential, most adult HSCs are found in the quiescent 
state (Cheshier et al., 1999; Wilson et al., 2008). The maintenance of quiescent fate is 
believed to be critical for stem cell maintenance and prevent proliferation-associated 
exhaustion (Orford and Scadden, 2008). Moreover, long-term BrdU incorporation 
experiments identified a highly quiescent sub-fraction of HSCs that divided only five 
times during the entire life of the mouse (Wilson et al., 2008) suggesting that these 
cells spend a majority of their time in a quiescent state.  Symmetric commitment 
divisions if carried out indefinitely result in the exhaustion of the stem cell pool. 
Recent work has shown that chronic IFNα mediated activation of HSCs result in 
competitive disadvantage in long-term repopulation assays (Essers et al., 2009). 
Similar effects were reported upon IFNγ treatment (de Bruin et al., 2014). But this 
fate choice is believed to be less relevant in a normal homeostatic environment. 
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Regulation of hematopoietic stem cell fate 
Tight regulation of HSC fate choice is important for life long maintenance of the 
blood system. Both, extrinsic cues from the niche and intrinsic HSC mechanisms are 
believed to regulate this process. Direct cell-cell adhesion and secreted cytokine 
mediated signals from the niche were shown to be critical for HSC maintenance 
(Figure 1.3). Stem cell factor (SCF), primarily expressed by osteoblasts (both as 
membrane bound form and secreted form), is one of the most important niche factors 
mediating HSC self-renewal (Miyazawa et al., 1995). Moreover, thrombopoietin 
(TPO) produced by niche cells, signals via the c-Mpl receptor on HSCs to promote 
self-renewal (Kimura et al., 1998; Solar et al., 1998). Exposure to various 
interleukins, such as IL-3, IL-6, and IL-11, results in rapid HSC proliferation, but 
leads to loss of long-term reconstitution potential (Peters et al., 1996). Moreover, 
osteopontin (OPN), secreted by osteoblasts has a negative effect on HSC number. 
OPN deficient mice were observed to have a two-fold increase in HSC number 
(Nilsson et al., 2005; Stier et al., 2005). This effect was shown to be primarily due to 
active maintenance of HSC quiescence by OPN (Nilsson et al., 2005). 
 
As mentioned above, maintenance of HSC quiescence is believed to prevent 
proliferation based stem cell exhaustion (Orford and Scadden, 2008). Genetic studies 
on key cell cycle genes supported this notion. Deletion of Cdk inhibitors, such as p21, 
p27, and p57, lead to increased cell cycle entry and eventually HSC exhaustion 
(Matsumoto et al., 2011; Yu et al., 2006; Zou et al., 2011). Furthermore, conditional 
deletion of Pten, a tumour suppressor gene, led to increased proliferation and a 
concomitant loss of long-term engraftment potential (Zhang et al., 2006). Ang-1/Tie2 
signaling was observed to be a key regulator of HSC quiescence. Ang-1 secreted by 
osteoblasts binds its receptor Tie2 on HSCs. Overexpression of Ang-1 resulted in 
increased HSC quiescence (Arai et al., 2004). Tie2 mediated signaling up regulated 
N-cadherin expression in HSCs, suggesting an increase in their anchoring in the 
endosteal niche by homotypic N-cadherin interaction with osteoblasts (Arai et al., 
2004).  
 
Additionally, many classical developmental signaling pathways have been shown to 
be relevant in HSC fate choice. Inhibition of notch signaling led to differentiation of 
HSCs in vitro and depletion of the HSC pool in vivo (Duncan et al., 2005). In vitro 
treatment with Wnt3a lead to increase in self-renewal capacity of HSCs, suggesting 
Wnt signaling as a promoter of HSC stemness (Fleming et al., 2008; Reya et al., 
2003; Willert et al., 2003). Strikingly, lentiviral transduction of HoxB4 or in vitro 
treatment with HoxB4 protein was shown to result in the expansion of the HSC pool 
(Antonchuk et al., 2002; Krosl et al., 2003). 
 
In addition to the cellular factors, the hypoxic environment of the niche is believed to 
play a key role in determining HSC fate choices by modulating various metabolic 
pathways (Ito and Suda, 2014; Suda et al., 2011) (Figure 1.5). Hypoxic culture 
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conditions induce quiescence (Hermitte et al., 2006; Shima et al., 2010) and result in 
increased reconstitution potential of HSCs (Cipolleschi et al., 1993; Danet et al., 
2003). Hypoxia inducible factor-1α (HIF-1a) was shown to be the master regulator 
controlling various intracellular pathways in HSCs in response to the low oxygen 
microenvironment (Takubo et al., 2010). HIF-1a deletion led to increased cell cycle 
entry and loss of long-term engraftment potential (Takubo et al., 2010). Furthermore, 
HIF-1a increases the glycolytic flux in HSCs by activating glucose transporters and 
different glycolytic enzymes such as HK, PFK, LDHA (Iyer et al., 1998; Takubo et 
al., 2013). Moreover, it was shown to actively prevent oxidative phosphorylation 
(OXPHOS) through a pyruvate dehydrogenase kinase (PDK) mechanism that inhibits 
pyruvate dehydrogenase (PDH) responsible for the conversion of pyruvate to acetyl-
CoA (Takubo et al., 2013) 
 
 
Figure 1.5: Metabolic regulation of Hematopoietic stem cell fate. Modified from (Ito and Suda, 
2014) 
 
Reactive oxygen species (ROS) primarily generated through mitochondrial oxidative 
phosphorylation were shown to have deleterious effects on HSC maintenance (Ito et 
al., 2004; Ito et al., 2006). To avoid ROS inflicted damage FOXO proteins activate 
expression of antioxidants such as super oxide dismutase and catalase, and therefore 
maintain HSC stemness (Jang and Sharkis, 2007; Miyamoto et al., 2007; Tothova et 
al., 2007). Several other reports propose a link between mitochondrial metabolism and 
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HSC fate. Inactivation of PTEN-like mitochondrial phosphatase (PTPMT1) was 
shown to block HSC differentiation divisions and subsequently lead to hematopoietic 
failure (Yu et al., 2013). Knocking down PGC-1a and PGC-1b, two key regulators of 
mitochondrial function and biogenesis, resulted in hematopoietic defects (Basu et al., 
2013; Sahin et al., 2011). Moreover, the tumor suppressor and glucose sensor Lkb1 
was shown to be crucial for HSC maintenance via a not yet fully understood 
mechanism involving mitochondrial biogenesis and function (Gan et al., 2010; 
Gurumurthy et al., 2010; Nakada et al., 2010). Additionally, recent work in the field 
has implicated the role of fatty acid oxidation in HSC fate decision. Inhibition of 
PPARδ or mitochondria fatty acid oxidation resulted in loss of the HSC pool by 
increased symmetric commitment divisions (Ito et al., 2012).  
 
Collectively, these data show that a complex network of signals and constant crosstalk 
between the niche and the HSCs is necessary for the regulation of HSC fate decisions 
in the bone marrow. Further understanding of this intricate regulatory process will 
enable development of new culture systems for better maintenance of HSCs in vitro, 
and could potentially allow identification of markers to fish out functional HSCs from 
heterogeneous in vitro cultures. 
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Abstract 
Although a majority of the adult hematopoietic stem cell (HSC) population is 
quiescent, their well-regulated cell divisions are necessary to maintain the stem cell 
pool and produce differentiated progeny to replenish the blood system. Divisional 
tracking using 5-bromo-2'-deoxyuridine (BrdU)-mediated DNA labeling, and 
carboxyfluorescein diacetate succinimidyl ester (CFSE)-based cytoplasmic labeling 
has shed light on steady state dynamics of HSC divisions in vivo. Cell cycle dynamics 
of HSCs cultured in predefined in vitro conditions have not been thoroughly 
characterized yet. Here, we used CFSE-based cell tracking combined with 
immunostaining to precisely map the phenotypic changes of HSCs that underwent up 
to four divisions, under culture conditions previously described to induce HSC self-
renewal, commitment or maintenance (basal condition). We found significantly 
higher proliferation rates in self-renewing and commitment-inducing conditions as 
compared to the basal culture condition. Preliminary analyses of cell division patterns 
showed that the self-renewing condition maintained a higher proportion of cells with 
the HSC immunophenotype. Moreover, the proportion of these HSCs decreased with 
increasing number of cell divisions, supporting the notion that faster HSC cycling 
results in stem cell exhaustion.  
 
Introduction 
Adult HSCs predominantly reside in a quiescent cell cycle state (Cheshier et al., 1999; 
Wilson et al., 2008). The maintenance of this quiescent state is believed to be 
necessary to prevent stem cell exhaustion (Orford and Scadden, 2008). On the 
contrary, HSC divisions are indispensable for self-renewal and the generation of 
committed daughters for lifelong production of mature blood cells. Therefore, a fine 
balance between quiescence and cycling is critical for long-term blood production 
without exhausting the HSC pool. Various studies have used cell-tracking methods to 
study the division dynamics of HSCs in their native niche. For instance, in vivo 
incorporation of BrdU in HSCs was used to demonstrate that these rare cells enter cell 
cycle within three weeks and divided homogenously, with every HSC undergoing a 
division once in 57 days (Cheshier et al., 1999). Other studies used transient 
expression of histone 2B protein fused with green fluorescent protein (H2B-GFP), or 
a short BrdU pulse, followed by a long chase period, to identify two distinct 
populations within the phenotypically defined HSCs; one that divided faster (~36 
days) and the other that divided much slower (~145 days) (Foudi et al., 2009; Wilson 
et al., 2008). Moreover, they demonstrated enhanced stem cell potential associated 
with the slower cycling fraction (Foudi et al., 2009; Wilson et al., 2008). Recent 
studies have tracked HSC divisions in vivo (Takizawa et al., 2011) by using 
carboxyfluorescein diacetate succinimidyl ester (CFSE), a cell permeable dye that is 
equally distributed in daughter cells upon division (Lyons and Parish, 1994; Weston 
and Parish, 1990). Interestingly, they found that both non-dividing (also termed 
“dormant”) and fast cycling cells possess long-term blood reconstitution potential. 
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Strikingly, fast cycling cells were capable of reverting back to the dormant state, 
suggesting that these cell cycle states are reversible (Takizawa et al., 2011).  
Similar studies to understand HSC cell cycle dynamics in predefined in vitro culture 
conditions are lacking. Earlier efforts could only identify a fast and a slow cycling 
population of cells using PKH-26, a lipophilic dye that non-covalently stains the cell 
membrane and distributes equally in daughter cells (Lee et al., 2002; Yan et al., 
2003). Staining of Lin- or a human progenitor cell line by PKH-26 allowed only a 
crude identification of fast (PKHlow/null) and slow (PKHhigh) cycling cells with no 
further resolution on the precise number of divisions and importantly, no relationship 
with immunophenotype (Yan et al., 2003; Lee et al., 2002).  
 
Here we employed CFSE labeling to systematically analyze HSC progeny in vitro. 
Building on the methods developed by Takizawa and colleagues (Takizawa et al., 
2011), we labeled freshly isolated HSCs (identified by Lin-cKit+Sca+CD150+CD48-
CD34-) with CFSE, and performed flow cytometry analysis at various time points to 
assess changes in CFSE intensity correlating with HSC divisional history. We thus 
successfully tracked up to five HSC divisions in culture. We found cells cultured in 
self-renewing and commitment conditions to have faster proliferation rates compared 
to the basal condition. Furthermore, preliminary experiments showed that self-
renewing condition maintained a higher proportion of cells retaining the HSC 
immunophenotype. The retention of HSCs negatively correlated with number of 
divisions, across all conditions. This finding is in congruence with the current view in 
the field that associates faster cycling with loss of stem cell activity (Orford and 
Scadden, 2008). Interestingly, even though the cycling rates of self-renewing and 
commitment condition were similar, changes in phenotype were found to be 
noticeably different, suggesting that external cues induce different stem cell fates. 
However, these experiments need to be repeated in order to confirm these preliminary 
findings. Altogether, this method allows high resolution tracking of HSC divisions in 
vitro, and can potentially be applied to isolate functional HSCs from different 
divisional states. 
 
Experimental methods 
Mice 
Mice were purchased from Charles River Laboratories International and maintained at 
the Center for Studying Living System (CAV) at the EPFL in micro-isolator cages. 
Mice were provided continuously with sterile food, water and bedding. All 
experiments were carried out in accordance with the Swiss law. 
 
Antibodies 
The following antibodies were used: cKit-PeCy7 (2B8, Biolegend), Sca1-APC (D7, 
Biolegend) or -PerCPCy5.5 (E13-E161.7, Biolegend), CD150-PeCy5 (TC-15-
12F12.2, Biolegend), CD48-PB (GM48-1, Biolegend), CD34-FITC or –efluor660 
(RAM34, eBiosciences), SAV-PO (life technologies). A mixture of biotinylated 
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mAbs against CD3, CD11b, CD45R/B220, Ly-6G, Ly-6C and TER-119 was used as 
lineage depletion cocktail (BD Biosciences). 
?
 
Flow cytometry and cell sorting  
Flow cytometry analysis of hematopoietic stem and progenitor cells was performed 
on freshly isolated bone marrow (BM) from 8-12 weeks old C57Bl/6J mice. BM was 
extracted from crushed femora, tibia and hip bone. Cell suspension was then filtered 
through a 70μm cell strainer and erythroid cells were eliminated by incubation with 
red blood cells lysis buffer (eBioscences). Lineage-positive cells were removed with a 
magnetic lineage depletion kit (Miltenyi Biotech). Cell suspensions were stained with 
a panel of specific antibodies for stem and progenitor cells and FACS-sorted on BD 
FACS Aria II. The long term Hematopoietic stem cell (HSC) compartment was 
identified and sorted with the following cell surface phenotype Lin- cKit+ Sca1+ 
(LKS) CD150+ CD48- CD34-. 
 
CFSE staining 
Freshly sorted HSCs were incubated for 20 min at 37°C with 1:400 CFSE stock 
solution  (Cayman chemicals; CFSE cell division assay kit). Cells were then pelleted 
and re-suspended in Stemline II (Sigma) containing 10% FBS for 20 min at 37°C. 
Thereafter, the cells were washed twice with Stemline II and put in culture. 
?
HSC culture 
Cells were cultured in U-bottom 96-well plates for three days at 5% CO2 at 37o C. 
Cultures were maintained in serum free media (Stemline II, Sigma) supplemented 
with a different set of cytokines for different conditions. The “Basal” media included 
addition of 100ng/ml SCF (R&D Systems), 2ng/ml Flt3 ligand (R&D) and 0.5% P/S. 
The “Self-renewing” media included 10μg/ml Heparin (Sigma), 100ng/ml SCF (R&D 
Systems), 2ng/ml Flt3 ligand (R&D), 20ng/ml TPO (R&D Systems), 10ng/ml FGF-1 
(Invitrogen), 500ng/ml IGFBP2 (R&D Systems), 100ng/ml AngL-3 (R&D Systems) 
and 0.5% P/S. The “Commitment” media included the addition of 20ng/ml IL-3 
(R&D Systems) and 100ng/ml IL-6 (R&D Systems) to the basal media. 
 
Post culture staining 
At the end of the culture period cells were recovered from U-bottom 96 well plates. 
Cells were then stained with a panel of specific antibodies and analyzed on BD 
LSRII. 
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Results and Discussion 
CFSE-based in vitro divisional tracking of HSCs 
To analyze the progeny of HSCs in their distinct divisional states we decided to 
employ CFSE-based in vitro divisional tracking. CFSE, a cell permeable dye is 
retained in the cells via covalent attachment to intracellular amines. Upon cell 
division the dye is equally distributed in daughter cells, hence diluting-out by a factor 
of two with every division (Lyons and Parish, 1994; Takizawa et al., 2011; Weston 
and Parish, 1990). Therefore, by uniformly labeling cells at the beginning of the 
culture and assessing the dilution of the dye (i.e intensity) at later time points, it is 
possible to precisely track the number of divisions a cell has undergone (Figure 2.1B). 
 
 
 
Figure 2.1: CFSE-based in vitro divisional tracking of HSCs. (A) Isolation of HSCs using flow cytometry. (B) 
Schematic of CFSE based divisional tracking of cells. CFSE dilutes out in every subsequent division. (C) CFSE 
based divisional tracking of HSCs, represented using histograms (above) and dot plots (below). Sharp peak 
corresponding to undivided cells was observed at the beginning of culture. Upto five HSC divisions could be 
precisely followed over a period of six days. Determination beyond 5 divisions with high resolution was not 
possible due to dilution of the dye. A representative example is shown here from the self-renewing condition. 
 
To ascertain if this method could be used to track HSC divisions in vitro, we FACS 
sorted HSCs based on a commonly used combination of cell surface markers, Lin- 
cKit+Sca1+ (LKS) CD150+CD48-CD34- (Kiel et al., 2005; Wilson et al., 2008) 
(Figure 2.1A) and uniformly labeled them with CFSE. A small fraction of the labeled 
cells were analyzed by flow cytometry to determine the CFSE intensity corresponding 
to undivided cells (Figure 2.1C, left panel Day 0). The remaining cells were put in 
culture and analyzed by flow cytometry at various time points until six days (Figure 
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2.1C). We observed the emergence of precise peaks of CFSE intensities 
corresponding to a step-wise increase in the number of cell divisions (Figure 2.1C). A 
predominant peak corresponding to “1 division” after two days and “2 division” after 
three days in culture was observed (Figure 2.1C). These observed division kinetics 
corresponded well with our previous analysis using live cell imaging at single cell 
level (Vannini et al., 2012) (Roch et al., submitted), and we therefore rule out changes 
in cell cycle characteristics upon CFSE staining. Importantly, previous studies have 
demonstrated that CFSE labeled LKS cells show long-term blood reconstitution, 
ruling out labeling related impairment of stem cell function (Takizawa et al., 2011). 
 
Linking HSC divisional history to phenotype in different culture conditions 
Having established in vitro divisional tracking of HSCs, we wanted to test their 
division kinetics in different in vitro culture conditions and correlate it to changes in 
phenotype. We therefore cultured CFSE-labeled HSCs in well defined in vitro 
conditions, previously identified as promoting either HSC self renewal (Huynh et al., 
2008; Huynh et al., 2011; Zheng et al., 2011), or commitment, i.e rapid loss of stem 
cell potential (Peters et al., 1996). In addition we used a minimal basal culture 
condition promoting HSC survival but also eventual loss of stem cell activity (Lutolf 
et al., 2009; Vannini et al., 2012). After three days in culture, HSC progeny generated 
in different culture conditions were stained with cell surface markers to assess their 
phenotype.  
 
 
 
Figure 2.2: Divisional kinetics in different culture. (A) HSCs cultured in different in vitro conditions 
(“commitment”, “basal”, and “self-renewal”) for 3 days. Commitment and self-renewing condition show faster 
proliferation with many cells having divided three or four times. Basal condition demonstrate slower proliferation 
with most cells having divided only once  (B) Estimation of proportion of cells in each division state in the three 
culture conditions. (C) Starting cell number was back calculated using the total final cell number and number of 
cells in each division (from B). Commitment and self-renewing condition showed around 5 and 3 fold expansion 
in cell number, respectively. Basal condition had less than 2 fold expansion in the same culture duration (3 days) 
n=1. (D) HSC marker staining in combination with CFSE based divisional tracking. Representative example 
shown here from the self-renewing condition. Different markers showed distinct expression patterns. Sca1 
expression dropped with increasing divisions, while cKit expression remained consistent across divisions. CD48 
expression starts coming up only after two cell divisions. Moreover, most cells showed high CD34 expression, in 
line with previous studies that showed CD34 expression coming up in cycling cells. Gates for each channel were 
drawn using the unstained control (Figure 2.6, check appendix). 
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First we assessed the division kinetics of HSCs cultured in different conditions for 
three days (Figure 2.2A-C). The basal condition demonstrated slowest division 
kinetics, with most cells having undergone only one division, and no cells with more 
than two divisions (Figure 2.2A,B). HSCs grown under commitment and self-renewal 
conditions demonstrated faster division rates (Figure 2.2A), with a higher proportion 
of cells undergoing three divisions (in commitment condition) and two divisions (in 
self-renewal condition) (Figure 2.2A,B). With the final cell number (Figure 2.2C, 
right panel) and divisional history (Figure 2.2A,B) known, we estimated the 
approximate starting cell number in each condition (Figure 2.2C, left panel), allowing 
us to calculate the fold-expansion in each culture conditions. We found the starting 
cell number in each condition to be around 500 cells. Expectedly, commitment (~4.8 
fold) and self-renewal (~3.2 fold) demonstrated higher expansion rates compared to 
the basal condition (~1.8 fold) in this experiment (n=1) (Figure 2.2C). Of note, since 
it is impossible to account for cells that could have died at different divisional states 
during the culture period, the initial cell number estimation is only approximate. 
 
Next, we determined the expression levels of different HSC markers in these cells. To 
this end, we re-stained the cells at the end of the culture period with all markers used 
to isolate the starting HSC population (cKit, Sca1, CD150, CD48, and CD34). Gates 
for each channel were drawn based on the unstained control (Figure 2.6, check 
appendix). The changes in stem cell marker expression as a function of the number of 
cell divisions was found to be very marker specific. For example, under self-renewal 
conditions, while Sca1 expression dropped gradually with every division, cKit 
appeared to remain relatively constant across the entire divisional history, whereas 
CD48 positive cells started appearing only after cells had undergone at least two 
division (Figure 2.2D). Interestingly, majority of the cells showed high CD34 
expression (Figure 2.2D), consistent with previous reports that demonstrated CD34 
expression being up regulated in activated HSCs (Ogawa et al., 2001). Moreover 
CD34 expression was shown to be reversible, with in vitro activated CD34+ cells 
capable of reverting back to a CD34 negative stem cell (Ogawa et al., 2001; Sato et 
al., 1999).  
 
HSC phenotype in different culture conditions 
As identification of HSCs is based on a unique combination of surface markers, we 
next looked at the entire repertoire of HSC and multipotent progenitor markers in 
different culture conditions (Figure 2.3). We did not stain cells with lineage markers, 
as it was difficult to incorporate additional colors in our immunostaining scheme for 
FACS analysis. Moreover, these markers are expressed only in more mature cells. 
First we identified the cKit+Sca1+ cells, a heterogeneous population known to 
contain HSCs and mostly progenitors (Okada et al., 1992). We found a higher 
proportion of cells (>50%) cultured in the self-renewing condition falling in this gate 
(Figure 2.3A, B{right graph}, whereas commitment and basal conditions retained 
only ~20% cells with these two markers (Figure 2.3A, B{right graph}). 
?
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Figure 2.3: HSC phenotype in different culture conditions. (A) Identification of cKit+Sca1+ population in the 
three culture conditions. (B) Actual cell number maintaining the cKit+Sca1+ phenotype. Self-renewing condition 
shows marked increase in the number of cells expressing these two markers as compared to the other two 
conditions (left graph). In comparison to initial cell number, self-renewing condition shows an increase (~1.4 fold) 
in the number of cells with this phenotype, suggesting that some HSCs underwent symmetric expansion division in 
this condition (middle graph). The other two conditions show only about 50% of the initial cell number retaining 
this phenotype (middle graph). More than 50% of the final cell number in the self-renewing condition maintained 
the cKit+Sca1+ phenotype, while the other two conditions had less than 25% (right graph). (C-D) Identification of 
cKit+Sca1+ in combination with the SLAM code (CD150+ CD48-). Similar trends were observed as seen with 
only cKit+Sca1+ population. Self-renewing condition was observed to have an increase (~1.2 fold) as compared to 
the initial cell number, indicating HSC expansion divisions (middle graph). Moreover, self-renewing condition had 
~40% of the final cell number retaining this phenotype, in contrast to the other two conditions, which had very low 
fraction in this gate; basal (~20%) and commitment (<5%) (right graph). (E-F) Identification of the CD34 
expression in addition to the population gated in C-D. Most cells were observed to be positive for CD34, in line 
with previous studies that linked CD34 expression to cycling. Expectedly, a very small fraction of cells (<5%) 
retained CD34 negativity at the end of the culture (right graph). Since, CD34 negativity becomes unreliable for the 
identification of HSCs when they are cycling, we decided to not include CD34 expression for further 
interpretations. (n=1) 
?
Furthermore, addition of the SLAM code (i.e differential expression of CD150 and 
CD48) to the cKit+Sca1+ population showed a similar trend, with self-renewing 
condition retaining close to 40% cells, while the commitment condition having less 
than 5% cells in this gate, primarily due to a marked increase of CD48 positivity 
(Figure 2.3C, D{right graph}). Moreover, most cells showed high levels of CD34, 
irrespective of the culture condition as they were actively cycling (Figure 2.5E), 
confirming earlier reports how CD34 negativity becomes unreliable to identify stem 
cells once they are cycling (Ogawa et al., 2001). However, this experiment needs to 
be repeated to confirm these observations. 
 
As expected, absolute cell number in the cKit+Sca1+ gate (Figure 2.3B, left graph) 
and cKit+Sca1+CD150+CD48- gate (Figure 2.3D, left graph), revealed a marked 
difference between the self-renewing and the other two conditions. Moreover, the 
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self-renewing condition showed an increase from the initial cell number (Figure 
2.3B,D, middle graph), indicating that this condition might facilitate symmetric 
expansion divisions in some cells (Huynh et al., 2008; Huynh et al., 2011; Zheng et 
al., 2011). Expectedly, under commitment and basal conditions, very few cells 
maintained these phenotypes, with the proportion going down to less than 40% of the 
initial cell number (Figure 2.3D, middle graph). Together, these data indicate that the 
self-renewing condition maintains a higher proportion of cells with the HSC 
phenotype compared to the other two conditions. Repetition of this analysis will be 
carried out in future to validate these initial findings. 
?
HSC phenotype across cell divisional history 
Previous studies have implicated a negative correlation between HSC cycling and 
stem cell potential (Orford and Scadden, 2008). Additionally, we observed that some 
stem cell markers such as Sca1 and CD48 change dramatically from slow- to fast- 
cycling cells (Figure 2.2D). Therefore, we next checked phenotypic changes across 
entire divisional history under various culture conditions, in this experiment (n=1). 
To this end, we determined the proportion of cells expressing these markers as a 
function of the number of cell divisions (Figure 2.4). Interestingly, we found that in 
both, cKit+Sca1+ and cKit+Sca1+CD150+CD48- populations, the proportion of cells 
decreased systematically with increasing divisions (Figure 2.4A, commitment 
condition shown as a representative example). This preliminary observation revealed 
a similar trend in all three culture conditions (Figure 2.4B,C), suggesting that the stem 
cell potential might be inversely related to cycling kinetics. 
 
 
 
Figure 2.4: HSC phenotype across cell division history. (A) Expression pattern of different phenotypes 
(cKit+Sca1+ (top panel), cKit+Sca1+CD150+CD48- (middle panel), and cKit+Sca1+CD150+CD48-CD34- 
(bottom panel), across different divisions (commitment condition shown as a representative example). (B-C) The 
proportion of cells maintaining the cKit+Sca1+ (B) and Ckit+Sca1+CD150+CD48- (C) phenotype goes down with 
increasing divisions across all three conditions. The self-renewing condition contained a high proportion of cells 
maintaining these phenotypes upto two divisions. Interestingly by the fourth division most cells had lost the basic 
cKit+Sca1+ phenotype. (D) As mentioned before most cells were observed to be positive for CD34 and therefore a 
very low fraction was seen to be CD34- across different divisions in all three conditions. (n=1) 
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Of note, the proportion of cKit+Sca1+ cells decreased with increasing divisions 
primarily due to a dramatic loss of Sca1 expression (Figure 2.4A{upper panel},B). 
Furthermore, we detected an increase of CD48 levels in many cells after the second 
division, contributing to the rapid loss of the stem cell phenotype (Figure 2.4A 
{middle panel}, C). Intriguingly, by the fourth division, majority of the progeny had 
lost the basic cKit+Sca1+ phenotype under commitment and self-renewing conditions 
(Figure 2.4B), suggesting that these rapidly dividing cells have lost their stem cell 
potential.  
 
Next we compared across culture conditions the marker expression for cells in a 
particular division state (Figure 2.5). We found that within the first two divisions the 
self-renewal condition promoted relatively higher proportion of phenotypic HSCs 
compared to the other two conditions (Figure 2.5A,B). As most cells lost the HSC 
phenotype after third division, the differences across conditions became much smaller 
(Figure 2.5A,B). This suggests that the first two divisions could be critical in 
maintaining stem cell phenotypes. These preliminary data reveal an interesting pattern 
in the dynamics evolution of HSC phenotypes, as a function of cell division history 
under different in vitro culture conditions, that can be further explored in future 
studies. 
?
Figure 2.5: Comparison of the HSC phenotype in particular divisional state in different conditions. (A-B) 
Estimation of the proportion of cells maintaining cKit+Sca1+ (A) and cKit+Sca1+CD150+CD48- (B) phenotype, 
in different division states. Upto two divisions the self-renewing conditions shows a high proportion of cells in 
these phenotypes as compared to “commitment” and “basal” conditions. After the third divisions the difference 
becomes less pronounced, and majority of the cells were seen to have lost the HSC phenotype by the fourth 
division. (C) Most cells had lost CD34 negativity, as they were actively cycling. (n=1) 
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Conclusions 
Here we established a novel framework for systematically assessing HSC behavior in 
culture, with a focus on cell division kinetics and phenotypic changes. By using CFSE 
based cell tracking we could reliably follow the precise number of HSC divisions in 
vitro. Moreover, combining divisional tracking with immunostaining allowed 
systematic analysis of the HSC progeny in different divisional states, under defined 
culture conditions imposing specific fates. Our preliminary findings indicate that 
compared to other conditions, the self-renewing cultures had the highest proportion of 
cells maintaining the HSC phenotype. However, this difference between different 
culture conditions became much smaller from third division onwards, suggesting the 
importance of the first two divisions in maintaining stem cell phenotypes in vitro. 
Importantly, we saw that the proportion of cells retaining the HSC phenotype 
systematically decreased with increasing number of cell divisions, supporting the 
current view in the field that correlates faster cycling with loss of stem cell activity 
via exhaustion. Collectively, these results shed light on distinct patterns in HSC 
phenotype expression in different divisional states in vitro. A thorough analysis with 
multiple repeats is being carried out at the moment to confirm these initial findings. 
Additionally, functional assays will be performed to confirm if this phenotype indeed 
correlates with long-term reconstitution potential in cultured cells. Finally, a 
comparative analysis between freshly isolated HSCs and cultured cells will be 
necessary to assess changes in marker expression due to in vitro culture. 
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Abstract 
A tight control of hematopoietic stem cell (HSC) fate is crucial for lifelong blood 
production. A fine balance of quiescence, self-renewal and differentiation are 
therefore key to maintain the HSC pool and at the same time produce progenitors to 
replenish various blood cell lineages. The mechanisms behind this regulation are still 
poorly understood. Here we show that mitochondrial activity is a key determinant of 
HSC fate. A low mitochondrial membrane potential (ΔΨm) predicts long-term multi-
lineage blood reconstitution capability for both, freshly isolated and in vitro-cultured, 
HSCs. However, as in vivo both quiescent and cycling HSCs have comparable ΔΨm 
distributions, a low ΔΨm is not per se related to quiescence but is also found in 
cycling cells. Indeed, using in vitro divisional tracking, we demonstrate that daughter 
HSCs with a low ΔΨm maintain long-term reconstitution potential, whereas daughter 
cells with high ΔΨm undergo differentiation. Strikingly, lowering the ΔΨm by 
chemical uncoupling of the electron transport chain leads to HSC self-renewal under 
culture conditions that normally induce rapid differentiation. Taken together, these 
data show that mitochondrial activity and fate choice are causally related in HSCs. 
 
Introduction 
The maintenance of the blood system is ensured by a pool of hematopoietic stem cells 
(HSCs) residing in poorly defined hypoxic niches in the bone marrow. These rare 
cells are capable of lifelong self-renewal and commitment to multipotent progenitors 
(MPP). For many decades, HSCs have been successfully used for the treatment of 
hematological and immune diseases, but their limited number prevents more reliable 
and broader applications of HSC-based therapies. Several attempts to propagate HSCs 
‘ex vivo’ have failed, because long-term self-renewal capacity is rapidly lost in 
culture. The lack of reliable phenotypic or genetic markers to distinguish self-
renewing HSCs from their earliest, functionally compromised progeny has made it 
difficult to elucidate the molecular mechanisms of self-renewal and fate decision-
making. Gaining knowledge on these aspects could enable the design of better 
strategies for clinical HSC manipulation. 
 
Classically, HSCs were identified by their ability to efflux the Hoechst dye through 
membrane transport pumps, and were shown to be enriched in the “side population” 
of Hoechst staining of LKS cells (Goodell et al., 1996). Recent advances in the field 
allow use of a combination of several surface markers to distinguish long-term HSCs 
(LT-HSC; Lin- cKit+ Sca-1+ (LKS) CD150+ CD34-) from short-term HSCs (ST-
HSC; LKS CD150+CD34+) and MPPs (LKS CD150- CD34+) in the mouse. 
Although the progression of LT-HSCs to ST-HSCs and MMPs is mirrored by only 
small changes in the repertoire of cell surface markers, an increasing body of work 
has shown that the change in cell identity and potency during early commitment 
involves a profound alteration in metabolic programs of the cells (Broxmeyer and 
Mantel, 2012; Ito et al., 2012; Ito and Suda, 2014; Suda et al., 2011; Takubo et al., 
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2013; Yu et al., 2013). LT-HSCs are mostly quiescent and fulfill their energy 
requirements predominantly through anaerobic glycolysis, which has been linked to 
their residence in low oxygen niches (Parmar et al., 2007; Simsek et al., 2010). In 
contrast, blood-producing stem and progenitor cell types with reduced self-renewal 
ability (i.e. ST-HSCs and rapidly proliferating MPPs) generate ATP primarily through 
mitochondrial oxidative phosphorylation (OXPHOS) (Takubo et al., 2013; Yu et al., 
2013). The distinct metabolic program of LT-HSCs appears to play a critical role in 
maintaining their long-term in vivo function. Accordingly, limiting mitochondrial 
respiration protects the cells from cellular damage inflicted by reactive oxygen 
species (ROS) in active mitochondria (Chen et al., 2008; Ito et al., 2004; Ito et al., 
2006; Tothova et al., 2007). Recent work in the field has shed light on some specific 
metabolic pathways and mechanisms by which HSC functionality is maintained. It 
was found that HSCs actively prevent OXPHOS through a pyruvate dehydrogenase 
kinase (PDK)-dependent mechanism that inhibits pyruvate dehydrogenase (PDH) 
responsible for the transformation of pyruvate to Acetyl-CoA (Takubo et al., 2013). In 
the same study HIF1α was shown to up regulate key glycolytic enzymes and therefore 
promote anaerobic glycolysis in HSCs (Takubo et al., 2013). Furthermore, knocking 
down PTEN-like mitochondrial phosphatase (PTPMT1) was shown to result in an 
induction of the uncoupling protein 2 (UCP2), diminishing the efficacy of OXPHOS 
and HSC differentiation (Yu et al., 2013). In addition, knocking out transcription 
factors PGC-1α and PGC-1β, two key regulators of mitochondria function and 
biogenesis, lead to similar detrimental defects in hematopoiesis (Basu et al., 2013; 
Sahin et al., 2011). Finally, the tumor suppressor and glucose sensor Lkb1 was shown 
to be crucial for HSC maintenance via a not yet fully understood mechanism 
involving mitochondrial biogenesis and function (Gan et al., 2010; Gurumurthy et al., 
2010; Nakada et al., 2010).  
 
Collectively, these data suggest that in HSCs, metabolism and function are intricately 
linked to each other. However, whether anaerobic glycolysis in HSCs is a cause or a 
consequence of this (hypoxic) niche induced quiescent state remains unclear. 
Furthermore, it is unknown how quiescent HSCs change their metabolism when they 
are activated and exit quiescence to undergo a self-renewal or differentiation division. 
To address these questions, here we used the mitochondrial membrane potential 
(ΔΨm), indicated by tetramethylrhodamine, methyl ester (TMRM) fluorescence, as a 
surrogate for the metabolic state of HSCs and MPPs. We show that phenotypically 
defined HSCs and progenitor cells vary substantially in their ΔΨm. Using in vivo 
multi-lineage blood reconstitution assays, we show that functional short-term and 
long-term self-renewal activity within each population is restricted to subpopulations 
having lower ΔΨm. Intriguingly, by comparing ΔΨm distributions of HSCs separated 
by their cell cycle phase, we found that during homeostasis as well as under acute 
stress, quiescent and cycling HSCs have relatively similar mitochondrial activity 
profiles. This shows that the distinct metabolic programs of HSCs are rather 
indicative of fate choice (i.e. self-renewal versus commitment) and not per se a 
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hallmark of the quiescent (versus activated) state.  Indeed, in vitro, in heterogeneous 
HSC expansion cultures, divisional tracking experiments show that actively self-
renewing HSCs retain a low ΔΨm, in marked contrast to differentiating cells that 
have activated mitochondria (high ΔΨm). Strikingly, low-dose chemical uncoupling 
of the electron transport chain forces HSCs to self-renew under culture conditions that 
normally induce rapid differentiation. Collectively, our data identify low 
mitochondrial activity as a potent functional marker of LT-HSCs and reveal an 
intriguing causal relationship between metabolism and fate. Therefore, HSC 
metabolism is more than an adaptation to a specific microenvironment in the bone 
marrow niche, but appears to be a requirement for cells to be able to execute a 
particular cell fate choice. 
 
Experimental methods 
Mice 
Mice were purchased from Charles River Laboratories International and maintained at 
the Center for Studying Living System (CAV) at the EPFL in micro-isolator cages. 
Mice were provided continuously with sterile food, water and bedding. All 
experiments were carried out in accordance with the Swiss law. 
 
Antibodies 
The following antibodies were used: cKit-PeCy7 (2B8, Biolegend), Sca1-APC (D7, 
Biolegend), CD150-PeCy5 (TC-15-12F12.2, Biolegend), CD48-PB (GM48-1, 
Biolegend), CD34-FITC (RAM34, eBiosciences), SAV-PO (life technologies), 
CD45.2-PB (104, Biolegend), CD45.1-FITC (A20, Biolegend), Gr1-APC (RB6-8C5, 
Biolegend), F4/80-APC (BM8, Biolegend), CD19-PE (6D5, Biolegend), CD3-PE 
(17A2, Biolegend). A mixture of biotinylated mAbs against CD3, CD11b, 
CD45R/B220, Ly-6G, Ly-6C and TER-119 was used as lineage depletion cocktail 
(BD Biosciences). 
?
Flow cytometry and cell sorting  
Flow cytometry analysis of hematopoietic stem and progenitor cells was performed 
on freshly isolated bone marrow (BM) from 8-12 weeks old C57Bl/6J mice. BM was 
extracted from crushed femora, tibia and hip bone. Cell suspension was then filtered 
through a 70μm cell strainer and erythroid cells were eliminated by incubation with 
red blood cells lysis buffer (eBioscences). Lineage-positive cells were removed with a 
magnetic lineage depletion kit (Miltenyi Biotech). Cell suspensions were stained with 
a panel of specific antibodies for stem and progenitor cells and analyzed or FACS-
sorted respectively on a BD LSRII and BD FACS Aria II.  
 
Analysis of mitochondrial activity 
Freshly isolated BM cells after RBC lysis were incubated at 37°C for 1 hour with 
200nM TMRM (Invitrogen) and then stained with specific antibodies for different 
hematopoietic stem/progenitor cell compartments. Labeled cells were FACS-sorted or 
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analyzed by flow cytometry. For confocal imaging, cells were sorted and placed on 
adherent poly-L-lysine (PLL)-coated glass slides for 6 hours at 37°C. 20nM TMRM 
was then added in the media and live cell images were acquired on a Leica SP5 
confocal microscope. For MitoTracker®Deep Red (Invitrogen) staining, cells were 
incubated at 200nM for one hour at 37°C.??
?
Transplantations  
Double congenic (CD45.1/45.2) marker system was used for all transplantations. 
CD45.2 mice were lethally irradiated (850RAD) and transplanted with donor cells 
isolated from CD45.1 mice and either competitor or helper cells from CD45.1/45.2 
mice. For LKS transplants, 1000 LKS (TMRMlow or TMRMhigh) donor cells were 
transplanted together with 250*103 total BM competitor cells in recipient mice. For 
LKS CD150+ CD34- (LT-HSC) and LKS CD150+ CD34+ (ST-HSC) transplants, 80 
donor cells were transplanted together with 250*103 total BM competitor cells in 
recipient mice. Recipient mice were bled at 4, 8 and 16 weeks post transplant and 
peripheral blood was stained with specific antibodies to determine donor-derived 
chimerism. One repopulating unit (RU) is equivalent to the repopulating ability of 
100,000 competitor bone marrow cells.  
 
For transplantation of in vitro-cultured LT-HSCs, the progeny of 200 LT-HSCs 
cultured for five days were FACS-sorted based on their TMRM signal (TMRMlow or 
TMRMhigh) and transplanted together with 2*106 helper cells. Helper cells were 
obtained from BM of CD45.1/45.2 mice that were depleted for Sca1+ and CD150+ 
cells using Sca1-PE (E13-161.7, Biolegend) and CD150-PE (TC15-12F12.2) 
antibodies and anti-PE microbeads (Miltenyi Biotech). Recipient mice were bled at 4, 
8 and 16 weeks post transplant and peripheral blood was stained with specific 
antibodies to determine donor-derived chimerism.  
 
For the CFSE-TMRM transplants, LT-HSCs were sorted and stained for CFSE. At the 
end of the 2-day culture period, cells were stained with TMRM followed by resorting 
based on TMRMlow and TMRMhigh signals in cells that have undergone one division. 
Each recipient mouse was injected with 100 cells of either population together with 
2*106 helper cells. Recipient mice were bled at 4, 8 and 16 weeks post transplant and 
peripheral blood was stained with specific antibodies to determine donor-derived 
chimerism. For transplants of HSCs exposed to the uncoupler FCCP, 100 LT-
HSC:TMRMlow cells were cultured for 5 days under differentiation-inducing 
conditions in the presence or absence of 5μM FCCP. The progeny of these 100 cells 
were transplanted in lethally irradiated recipient mice together with 2*106 helper cells. 
Recipient mice were bled at 4, 8 and 16 weeks post transplant and peripheral blood 
was stained with specific antibodies to determine donor-derived chimerism. 
 
Secondary Transplantation: Secondary recipients CD45.2 mice were lethally 
irradiated (850RAD) and transplanted with 3 million BM cells from the primary 
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recipients. Recipient mice were bled at 8 and 16 weeks post transplant and peripheral 
blood was stained with specific antibodies to determine donor-derived chimerism. 
?
Cell cycle analysis 
FACS sorted HSCs were fixed and permeabilized using Cytofix/Cytoperm plus kit 
(BD Biosciences), according to the manufacturer instruction. Cells were then stained 
overnight with Ki67 FITC (BD Biosciences) at 4°C, and 10 minutes with Hoechst 
33342 (Invitrogen).  
 
In vivo activation of HSC 
HSC were activated to exit dormancy by interferon-alpha (IFN-α) treatment 
following published protocols (Essers et al., 2009). Briefly, subcutaneous injections in 
C57Bl/6J mice were carried out with 10,000U of IFN-α (R&D systems) 48 and 24 
hours prior to bone marrow extraction. Control mice were injected with an equivalent 
volume of the vehicle (PBS + 0.1% BSA). 
 
CFSE staining 
Freshly sorted LT-HSCs were incubated for 20 min at 37°C with 1:400 CFSE stock 
solution  (Cayman chemicals; CFSE cell division assay kit). Cells were then pelleted 
and re-suspended in Stemline II (Sigma) containing 10% FBS for 20 min at 37°C. 
Thereafter, the cells were washed twice with Stemline II and put in culture. 
 
HSC culture 
Cells were cultured in U-bottom 96-well plates at 5% CO2 and 37o C. Cultures were 
maintained in serum free media (Stemline II, Sigma) supplemented with 10μg/ml 
Heparin (Sigma), 100ng/ml SCF (R&D Systems), 2ng/ml Flt3 ligand (R&D), 20ng/ml 
TPO (R&D Systems), 10ng/ml FGF-1 ((Invitrogen), 500ng/ml IGFBP2 (R&D 
Systems), 100ng/ml AngL-3 (R&D Systems). At the end of the culture period cells 
were stained with TMRM and analyzed or sorted by flow cytometry. To induce 
differentiation, HSCs were cultured in basal medium (Stemline II containing 
100ng/ml SCF and 2ng/ml Flt3 ligand) supplemented with 20ng/ml IL-3 (R&D 
Systems) and 100ng/ml IL-6 (R&D Systems). For uncoupler experiments, 5μM 
carbonyl cyanide 4-(trifluoromethoxy) phenylhydrazone (FCCP) (Sigma) was added 
at the medium. FCCP stock solution was prepared by dissolving the powder in ethanol 
at 10mM concentration. 
 
Colony forming unit (CFU) assay 
Colony forming unit (CFU) assays were performed in complete M3434 
methylcellulose (Stem Cell Technologies) following the manufacturer’s instructions. 
15’000 whole bone marrow or 100 LT-HSC:TMRMlow cells were plated in 
methylcellulose after two days of culture in the presence or absence of FCCP. 
Colonies were scored after 8 days or 21 days for total bone marrow and LT-
HSC:TMRMlow cells, respectively. 
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Statistics 
Data were statistically analyzed by Student’s t-test, one-way ANOVA followed by 
Bonferroni’s multiple comparison test and Mann Whitney test. 
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Results and Discussion 
Phenotypically defined HSC and progenitor cells show distinct ΔΨm 
We identified HSCs and their closely related progeny based on a commonly used 
combination of surface markers (Kiel et al., 2005; Osawa et al., 1996; Wilson et al., 
2008) and analyzed their ΔΨm levels by flow cytometry and confocal microscopy 
(Figure 3.1). We used TMRM, a cell permeable dye that is readily sequestered by 
active (polarized) mitochondria, as a read-out of mitochondrial activity. Different 
fractions in the hematopoietic hierarchy were separated based on Lin, Ckit, Sca1, 
CD150, and CD34 cell surface markers (Figure 3.1A). Flow cytometry analysis 
revealed distinct levels of TMRM intensity in different populations, with a stepwise 
increase from the most primitive to the most committed population (Figure 3.1B, data 
from Prof. Olaia Naveiras). Furthermore, confocal imaging of different populations 
confirmed that indeed more primitive fractions have significantly lower amount of 
active mitochondria (Figure 3.1C,D, data from Dr. Nicola Vannini), with signals 
becoming barely detectable in LT-HSCs.  
 
These data supports the idea that mitochondrial activity is limited in the most 
primitive HSC population, most likely as a strategy to protect them from ROS 
inflicted cellular damage (Ito et al., 2006; Jang and Sharkis, 2007; Piccoli et al., 2005; 
Tothova et al., 2007). In contrast, hematopoietic progenitors that are highly 
proliferative meet their increasing energy requirement by increasing mitochondrial 
metabolism, presumably through OXPHOS (Suda et al., 2011; Yu et al., 2013). 
 
 
Figure 3.1: Phenotypically defined hematopoietic stem and progenitor cell populations show distinct ΔΨm. 
(A) Isolation by FACS of commonly used, phenotypically defined hematopoietic stem and progenitor populations. 
Committed progenitors, CPs: c-Kit+; LKS: Lin- c-Kit+ Sca-1+ (i.e. a population that comprises all multipotent 
stem and progenitor cells in the bone marrow); short-term HSCs: LKS CD150+ CD34+ (ST-HSC); long-term 
HSCs: LKS CD150+ CD34- (LT-HSC). (B) Flow cytometry analysis of CPs, LKS, ST-HSC and LT-HSC based 
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on ΔΨm labeled with TMRM. Each population is marked by a differential ΔΨm level with a stepwise increase 
from the most primitive to the most committed population. (C,D) Confocal imaging and image analysis of live 
TMRM-labeled stem/progenitor cells confirms an increase of ΔΨm with increasing commitment level (n=7). 
Three representative examples are shown for each cell population (D). ***P< 0.001, **P< 0.01 and *P< 0.05 
 
Low ΔΨm marks HSC subpopulations with long-term blood reconstitution 
capacity 
Having already established that HSCs have lower mitochondrial activity as compared 
to the progenitors, we wanted to test if ΔΨm could be used to identify functional 
HSCs from the LKS fraction (a heterogeneous population that contains HSCs and 
predominantly progenitor cells) in the bone marrow. We used in vivo multi-lineage 
blood reconstitution assays as a read-out of long-term stem cell function (Figure 
3.2A). Engraftment was measured as repopulation unit (RU), one RU being 
equivalent to the repopulation ability found in 100,000 competitor bone marrow cells. 
 
To this end, we first isolated by FACS LKS subpopulations separated by low 
(LKS:TMRMlow) and high (LKS:TMRMhigh) ΔΨm levels. Transplantation of these 
two metabolically different phenotypes into lethally irradiated mice was performed 
using a double congenic allelic system (Figure 3.2A). Long-term multi-lineage blood 
reconstitution analysis showed that within the LKS population, only cells with low 
ΔΨm (i.e. LKS:TMRMlow) possess long-term multi-lineage blood reconstitution 
potential (Figure 3.2B,C). Therefore, the addition of a metabolic read-out to the 
existing surface marker repertoire allowed for purification of cells with long-term 
reconstitution capacity from a poorly defined population (LKS) containing mainly 
progenitors. We then extended the same sorting strategy to ST-HSCs (LKS 
CD150+CD34+), and compared ST-HSC:TMRMlow and ST-HSC:TMRMhigh for their 
ability to reconstitute the blood system in irradiated recipients (Figure 3.2D,E). 
Strikingly, within the ST-HSC population, short-term multi-lineage reconstitution 
capacity was almost exclusively restricted to the TMRMlow fraction (Figure 3.2E) as 
demonstrated by a peak in engraftment at 4 weeks followed by a drop at later time 
points (8 and 16 weeks). Furthermore, phenotypically defined LT-HSCs (LKS 
CD150+CD34-) could be separated into two distinct populations with low (LT-
HSC:TMRMlow) and high (LT-HSC:TMRMhigh) mitochondrial activity (Figure 3.2D), 
where long term multi lineage reconstitution was restricted exclusively to the “low” 
fraction  (Figure 3.2F). 
 
We reanalyzed the four populations (based on CD34 and TMRM signal) by flow 
cytometry immediately after sorting (Figure 3.6, check appendix) and saw that the 
fractions remain almost exclusively in their respective gates, confirming that our 
metabolically defined populations are distinct and stable.  More importantly 
propidium iodide (PI) staining did not show any measurable difference in viability 
between the four populations, even after 24 hours in culture (Figure 3.7, check 
appendix), ruling out that the lack of engraftment was a result of differential cell 
viability. 
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Figure 3.2: Low ΔΨm exclusively marks HSC subpopulations with multi-lineage reconstitution capacity. 
(A) Competitive transplantation strategy used to assess multi-lineage blood reconstitution levels from peripheral 
blood after 4,8 and 16 weeks. Engraftment is measured here as repopulating unit (RU), one RU being equivalent to 
the repopulating ability found in 100,000 competitor bone marrow cells. (B,C) Within LKS, containing all 
multipotent stem and progenitor cells in the bone marrow, long-term stemness is restricted to TMRMlowcells 
(LKS:TMRMlow) (n=8 for each condition). (D,E) In the phenotypically defined ST-HSC compartment, stemness is 
restricted to TMRMlow cells (ST-HSC:TMRMlow) (n=9 for each condition). (D,F) In the phenotypically defined 
LT-HSC compartment, stemness is restricted to TMRMlow cells (LT-HSC:TMRMlow) (n=9 for each 
condition).***P< 0.001, **P< 0.01 and *P< 0.05 
 
Our in vivo data thus reveals a striking functional heterogeneity in phenotypically 
defined HSCs. The observation that LT-HSCs with activated mitochondria (i.e. LT-
HSC:TMRMhigh) do not show blood reconstitution (Figure 3.2F), suggests that these 
cells may not be hierarchically related to ‘true’ LT-HSCs. They may instead represent 
HSCs that give rise to long-term lineage-restricted progenitor cells, as shown by 
recent in vivo single-cell multi-lineage reconstitution assays performed on the same 
immunophenotypes (Yamamoto et al., 2013). 
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Quiescent and cycling HSCs in the bone marrow have similar ΔΨm distributions  
Next, we wanted to test if quiescent and cycling LT-HSCs have similar levels of 
mitochondrial activity, i.e. that low ΔΨm is a hallmark of stemness independent of the 
cell cycle state. To this end, we performed cell cycle phase analyses using Ki67 and 
Hoechst staining on freshly isolated LT-HSCs, and looked at the mitochondrial 
activity of the quiescent and cycling fraction. Since cell cycle staining involves cell 
fixation that is not compatible with TMRM-based assays, we used MitoTracker Deep 
Red as a marker for ΔΨm (Simsek et al., 2010) for these experiments. This dye labels 
ΔΨm in stem and progenitor cells comparable to TMRM, with a step wise increase in 
intensity moving from the most primitive to the most committed fraction (Figure 3.8, 
check appendix). 
 
 
 
Figure 3.3:  Quiescent and cycling HSC populations in the native niche have comparable mitochondrial 
activity levels. (A) Cell cycle analysis using Ki67 and Hoechst staining on freshly isolated HSCs indicate that 
more than 70% of the cells are in a quiescent state (G0, red), with the remaining cells cycling (G1 + S/G2-M, 
green). (B) Flow cytometry analysis of quiescent and cycling HSCs based on ΔΨ? labeled with MitoTracker® 
Deep Red. Both, quiescent and cycling HSCs show overlapping ΔΨ? profiles. The proportion of ΔΨ?low and 
ΔΨ?high cells within the quiescent and cycling HSC populations is similar (ΔΨ?low: P=0.44, ΔΨ?high P=0.81). 
(C) IFN-α stimulation results in in vivo activation of HSCs as demonstrated by Hoechst/Ki67 staining. (D) Flow 
cytometry analysis shows overlapping ΔΨm profiles of quiescent and cycling HSCs in IFN-αcondition. Similarly, 
the proportion of ΔΨ?low and ΔΨ?high cells in quiescent and cycling HSCs remains comparable (ΔΨ?low: P=0.32, 
ΔΨ?high P=0.54), suggesting that mitochondrial activity is independent of HSC cell cycle state even under acute 
stress conditions. 
 
Under homeostatic conditions, quiescent HSCs (identified by 2n DNA content and 
low Ki67) correspond to ~70% of cells, while cycling HSCs (identified by high Ki67) 
correspond to ~30% of cells (Figure 3.3A). Intriguingly, both these subfractions had 
nearly indistinguishable ΔΨm distributions (Figure 3.3B). We next performed a 
similar analysis on HSCs that were activated to exit dormancy directly in vivo using 
interferon-alpha (IFN-α) treatment of mice (Essers et al., 2009). To this end, we 
performed subcutaneous injections of IFN-α  48 and 24 hours prior to isolation of 
HSCs. Compared to control mice, IFN-α treatment resulted in a significant increase in 
the number of cycling (Ki67+) HSCs from 30 to 50% (Figure 3.3C), in line with 
previous reports (Essers et al., 2009). However, just like under homeostatic 
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conditions, ΔΨm distributions of quiescent and cycling HSCs were not significantly 
different (Figure 3.3D). This data shows that in vivo, low ΔΨm is not per se a 
hallmark of quiescent HSCs, but rather a functional marker for their stemness 
independent of cell cycle status. 
 
Low ΔΨm marks self-renewing HSCs in culture 
Having established low ΔΨm as a functional discriminator of stemness and revealing 
comparable ΔΨm levels of quiescent and cycling LT-HSCs in vivo, we sought to test 
whether ΔΨm levels would discriminate self-renewing from differentiating HSCs in 
heterogeneous bulk in vitro cultures (Figure 3.4). Like previously, we used in vivo 
multi-lineage blood reconstitution assays as readout of long-term stem cell function. 
To this end, we isolated LT-HSCs from CD45.1 mice based on surface marker 
expression and expanded in vitro in serum-free medium containing a cocktail of self-
renewing factors Angiopoietin-like protein, Insulin-like growth factor binding protein 
2, stem cell factor, fibroblast growth factor 1 and thrombopoietin (Huynh et al., 2008; 
Huynh et al., 2011; Zhang et al., 2006; Zheng et al., 2011) (Figure 3.4A). After 5 days 
in culture, cells were resorted based on TMRMlow and TMRMhigh phenotypes, and 
transplanted into lethally irradiated CD45.2 recipient mice. Consistent with our 
previous results, low TMRM signal was also predictive of the long-term blood 
reconstitution capacity of cultured HSCs (Figure 3.4B). Analysis of peripheral blood 
chimerism 16 weeks post transplantation showed significantly higher levels of 
reconstitution in mice injected with TMRMlow cells (Figure 3.4B). This data suggests 
that self-renewing HSCs in culture can be detected based on the same metabolic read-
out as freshly isolated HSCs from the bone marrow (Figure 3.2F). 
 
However, it is known that a small fraction of cultured HSCs can maintain their stem 
cell potential by remaining quiescent even after prolonged time in culture (Lutolf et 
al., 2009; Yamazaki et al., 2006), therefore reconstitution from TMRMlow cells seen in 
Figure 3.4B might have come from non-dividing HSCs. To exclude this possibility 
and unequivocally identify self-renewing cells in these bulk cultures, we devised a 
cell-labeling strategy that allowed us to track the precise number of divisions an HSC 
had undergone in culture (Figure 3.4C). Freshly isolated LT-HSCs were uniformly 
labeled with carboxyfluoresceinsuccinimidyl ester (CFSE), a live cell-permeable dye 
that gets diluted with every cell division such that CFSE intensity is decreased by 
~50% upon each division (Takizawa et al., 2011). Post CFSE staining, cells were put 
in culture for 2 days to allow the majority of them to divide. At the end of the culture 
period cells were stained with TMRM to prepare them for sorting. By these means, 
we FACS-sorted cultured HSCs that underwent precisely one division after two days 
and further separated them into TMRMlow and TMRMhigh sub-populations (Figure 
3.4C, lower panels). 100 cells of each population were transplanted into lethally 
irradiated mice and long-term multi lineage reconstitution was analyzed up to 16 
weeks. In line with our previous findings, long-term multi lineage blood 
reconstitution was restricted to the TMRMlow subpopulation (Figure 3.4D).  
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Figure 3.4: A low ΔΨm marks self-renewing HSCs in culture. (A) TMRMlowand TMRMhigh cells of 5-day in 
vitro-expanded LT-HSCs were FACS-sorted and transplanted into lethally irradiated mice together with helper 
cells (Sca1-, CD150-). Multi-lineage blood reconstitution was measured at 4,8 and16 weeks (n=12 for each 
condition). (B) The TMRMlow cell fraction of culture-expanded HSC progeny show higher chimerism compared to 
TMRMhigh cells. (C) CFSE-labeled LT-HSCs were cultured under expansion conditions for two days and progeny 
that underwent one division were sorted into TMRMlow and TMRMhigh phenotypes and transplanted into lethally 
irradiated recipient mice together with helper cells. (D) The TMRMlow fraction of the first generation of daughter 
cells (i.e. dividing one time) exhibited strikingly higher long-term multi-lineage blood reconstitution efficiency 
compared to TMRMhigh cells, providing evidence for self-renewing versus differentiating HSC divisions in culture 
(n=10 for each condition). Assessment of blood chimerism is shown for total blood (top panel) as well as the 
lymphoid and myeloid lineages (bottom panels). (E) BM derived from each of the TMRMlow primary recipients 
(from D) was injected into four secondary recipient mice after one year of the primary transplant. Blood chimerism 
(average of 4 secondary recipients corresponding to each primary recipient) show long-term multi-lineage 
reconstitution in secondary transplants. ***P< 0.001, **P< 0.01 and *P< 0.05 
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To further consolidate our findings that indeed  TMRMlow cells were long term HSCs, 
we performed secondary transplantation after a period of one year (Figure 3.4E). 
Bone marrow derived from each of the TMRMlow primary recipients was injected into 
four secondary recipients  (3 million cells each). Blood analysis revealed high level of 
long term multi lineage reconstitution in all secondary recipients (Figure 3.4E), 
confirming that low TMRM signal allows for successful isolation of functional self 
renewing long term HSCs from bulk cultures. 
 
HSC fate conversion by electron transport chain uncoupling 
Finally, we decided to test whether low mitochondrial activity is a determinant or a 
consequence of HSC function. More specifically we tested whether HSC fate could be 
altered by modulation of mitochondrial activity. We chose culture conditions that 
would push HSCs to differentiate, and asked whether blocking the establishment of a 
high ΔΨm would result in the maintenance of stemness. For that purpose, we used 
trifluoro carbonyl cyanide phenylhydrazone (FCCP) that permeabilizes the inner 
mitochondrial membrane and disrupts its potential (Figure 3.9, check appendix), 
uncoupling electron transport from ATP generation. We saw a concentration-
dependent lowering of ΔΨm upon addition of FCCP (Figure 3.9, check appendix). 
We chose 5μM FCCP, as it was found to be the ideal concentration that resulted in 
reasonable lowering of ΔΨm without compromising on the viability of the cells 
(Figure 3.9, check appendix).  
 
In a first series of experiments, we used quantitative clonal differentiation assays to 
test to which extent mitochondrial uncoupling could influence the colony forming 
behavior and efficiency of hematopoietic stem and progenitor cells (Figure 3.5A-D, 
data from Prof. Olaia Naveiras). 15’000 whole bone marrow cells cultured under 
differentiation conditions (SCF, Flt3, IL-3 and IL-6) for two days in the presence of 
FCCP showed a striking decrease in the total number of colonies, as well as an 
increase in the percentage of multi-lineage colonies (CFU-GEMMs: colony forming 
unit-granulocyte, erythrocyte, macrophage, megakaryocyte), which originate only 
from the most primitive progenitor cells (Figure 3.5B, right panel). In contrast, the 
percentage of lineage-restricted colonies derived from more committed progenitors 
(e.g. macrophage colonies, M, granulocyte/macrophage colonies, GM) were markedly 
decreased (Figure 3.5B, middle panel). Similarly, when 100 LT-HSC:TMRMlow cells 
were first cultured for two days under differentiation conditions in the presence or 
absence of FCCP (Figure 3.5C), we saw a striking decrease in the frequency of 
colonies derived from the more committed progenitors (Mk, G,M and GM) (Figure 
3.6D, left and middle panel) and a concomitant increase of the highly proliferative 
colonies derived from the most primitive cells (CFU-GEMM) when cultured with 
FCCP (Figure 3.5D, right panel). These experiments suggested that mitochondrial 
uncoupling slows down rapid HSC differentiation, maintaining the cells in a more 
primitive, multipotent state.   
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Next, we performed long-term blood reconstitution assays wherein LT 
HSC:TMRMlow cells were cultured for five days under differentiation-inducing 
condition (SCF, Flt3, IL-3 and IL-6) (Peters et al., 1996) in the presence or absence of 
FCCP, and transplanted all progeny into lethally irradiated mice (Figure 3.5E). 
Strikingly, FCCP-exposed cells showed much higher levels of long-term multi-
lineage blood reconstitution in recipient mice (Figure 3.5F). Importantly, by labeling 
HSCs with CFSE and tracking their divisional history, we could rule out that this 
effect was due to an induction of quiescence upon FCCP administration, as all cells in 
culture had divided multiple times (Figure 3.10, check appendix).  This data clearly 
demonstrates that by disrupting the inner mitochondrial membrane potential, HSCs 
that would normally rapidly differentiate can be converted to undergo self-renewal 
divisions. Interestingly, self-renewing embryonic stem cells also have mitochondria 
with a low ΔΨm, indicative of high rates of glycolysis (Kondoh et al., 2007). 
Furthermore, during reprogramming of fibroblasts to the induced pluripotent stem cell 
state, a metabolic switch from OXPHOS to glycolysis is required (Folmes et al., 
2011).  
 
 
 
Figure 3.5: Modulation of mitochondrial metabolism alters HSC fate. (A,C) Short- and long-term colony 
forming unit (CFU) assays for measuring the influence of electron transport chain uncoupling on hematopoietic 
stem and progenitor cell differentiation. (B,D) Total bone marrow cells (B) as well as phenotypic LT-
HSC:TMRMlow (D) showed a significant decrease in the formation of less primitive and a concomitant increase in 
the proportion of more primitive colony types when mitochondria were uncoupled. In short-term (8 day) assays, 
the total number of colonies from bone marrow cells is significantly lower in the presence of the uncoupler (B, 
panel left), suggesting that FCCP might slow down colony formation by enforcing self-renewal over 
differentiation. (CFU-)G: Colony forming unit-granulocyte; (CFU-)M: Colony forming unit-macrophage; (CFU-
)GM: Colony forming unit-granulocyte, macrophage; (CFU-)GEMM: Colony forming unit-granulocyte, 
erythrocyte, macrophage, megakaryocyte); Mk/BFU-E: Megakaryocyte/Burst forming unit-erythroid. Photographs 
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of two representative examples of each experimental condition (+/- FCCP) reveal highly proliferative GEMM 
colonies (white) that are visible by naked eye when in presence of FCCP mitochondrial uncoupling (C, top panel 
on right). (E) LT-HSC:TMRMlow cultured for 5 days under differentiation conditions in the presence or absence of 
FCCP were transplanted in lethally irradiated recipient mice together with 2*106 helper cells. (F) Cells cultured in 
the presence of FCCP show high levels of multi-lineage reconstitution, in contrast to controls lacking FCCP that 
result in rapid differentiation. ***P< 0.001, **P< 0.01 and *P< 0.05 
 
Conclusions 
We found a simple yet powerful approach of predicting and directing HSC fate based 
on mitochondrial activity. By adding a mitochondrial activity-based read-out to the 
existing surface marker repertoire, we are able to further purify functional 
hematopoietic stem cells by removing a cell population (LT-HSC:TMRMhigh) that 
lacks long term multi-lineage blood reconstitution. Importantly, we found that this 
read-out marked functional HSCs independent of cell cycle status. Moreover, ΔΨm 
could be used to successfully isolate functional self-renewing HSCs from 
heterogeneous cultures. Importantly, we show that in vitro modulation of 
mitochondrial activity by treatment with an uncoupler can re-direct HSCs fate from 
rapid differentiation to self-renewal, suggesting that low mitochondrial activity is a 
cause of HSC stemness and not a consequence of a hypoxic bone marrow niche. 
These results provide evidence for the pivotal role of mitochondrial metabolism in 
HSC fate determination and suggest novel avenues for ‘ex vivo’ expansion and 
identification of HSCs for therapeutic manipulation. 
 
References 
Basu, S., Broxmeyer, H.E., and Hangoc, G. (2013). PGC-1alpha Mediated 
Mitochondrial Biogenesis is Important for Hematopoietic Recovery in Response to 
Stress. Stem Cells Dev. 
Broxmeyer, H.E., and Mantel, C. (2012). A ROSy future for metabolic regulation of 
HSC division. Nat Med 18, 1334-1336. 
Chen, C., Liu, Y., Liu, R., Ikenoue, T., Guan, K.L., and Zheng, P. (2008). TSC-
mTOR maintains quiescence and function of hematopoietic stem cells by repressing 
mitochondrial biogenesis and reactive oxygen species. J Exp Med 205, 2397-2408. 
Essers, M.A., Offner, S., Blanco-Bose, W.E., Waibler, Z., Kalinke, U., Duchosal, 
M.A., and Trumpp, A. (2009). IFNalpha activates dormant haematopoietic stem cells 
in vivo. Nature 458, 904-908. 
Folmes, C.D., Nelson, T.J., Martinez-Fernandez, A., Arrell, D.K., Lindor, J.Z., Dzeja, 
P.P., Ikeda, Y., Perez-Terzic, C., and Terzic, A. (2011). Somatic oxidative 
bioenergetics transitions into pluripotency-dependent glycolysis to facilitate nuclear 
reprogramming. Cell Metab 14, 264-271. 
Gan, B., Hu, J., Jiang, S., Liu, Y., Sahin, E., Zhuang, L., Fletcher-Sananikone, E., 
Colla, S., Wang, Y.A., Chin, L., et al. (2010). Lkb1 regulates quiescence and 
metabolic homeostasis of haematopoietic stem cells. Nature 468, 701-704. 
Chapter 3: Mitochondrial activity and HSC fate 
? ???
Goodell, M.A., Brose, K., Paradis, G., Conner, A.S., and Mulligan, R.C. (1996). 
Isolation and functional properties of murine hematopoietic stem cells that are 
replicating in vivo. J Exp Med 183, 1797-1806. 
Gurumurthy, S., Xie, S.Z., Alagesan, B., Kim, J., Yusuf, R.Z., Saez, B., Tzatsos, A., 
Ozsolak, F., Milos, P., Ferrari, F., et al. (2010). The Lkb1 metabolic sensor maintains 
haematopoietic stem cell survival. Nature 468, 659-663. 
Huynh, H., Iizuka, S., Kaba, M., Kirak, O., Zheng, J., Lodish, H.F., and Zhang, C.C. 
(2008). Insulin-like growth factor-binding protein 2 secreted by a tumorigenic cell 
line supports ex vivo expansion of mouse hematopoietic stem cells. Stem Cells 26, 
1628-1635. 
Huynh, H., Zheng, J., Umikawa, M., Zhang, C., Silvany, R., Iizuka, S., Holzenberger, 
M., Zhang, W., and Zhang, C.C. (2011). IGF binding protein 2 supports the survival 
and cycling of hematopoietic stem cells. Blood 118, 3236-3243. 
Ito, K., Carracedo, A., Weiss, D., Arai, F., Ala, U., Avigan, D.E., Schafer, Z.T., 
Evans, R.M., Suda, T., Lee, C.H., et al. (2012). A PML-PPAR-delta pathway for fatty 
acid oxidation regulates hematopoietic stem cell maintenance. Nat Med. 
Ito, K., Hirao, A., Arai, F., Matsuoka, S., Takubo, K., Hamaguchi, I., Nomiyama, K., 
Hosokawa, K., Sakurada, K., Nakagata, N., et al. (2004). Regulation of oxidative 
stress by ATM is required for self-renewal of haematopoietic stem cells. Nature 431, 
997-1002. 
Ito, K., Hirao, A., Arai, F., Takubo, K., Matsuoka, S., Miyamoto, K., Ohmura, M., 
Naka, K., Hosokawa, K., Ikeda, Y., et al. (2006). Reactive oxygen species act through 
p38 MAPK to limit the lifespan of hematopoietic stem cells. Nat Med 12, 446-451. 
Ito, K., and Suda, T. (2014). Metabolic requirements for the maintenance of self-
renewing stem cells. Nat Rev Mol Cell Bio 15, 243-256. 
Jang, Y.Y., and Sharkis, S.J. (2007). A low level of reactive oxygen species selects 
for primitive hematopoietic stem cells that may reside in the low-oxygenic niche. 
Blood 110, 3056-3063. 
Kiel, M.J., Yilmaz, O.H., Iwashita, T., Terhorst, C., and Morrison, S.J. (2005). SLAM 
family receptors distinguish hematopoietic stem and progenitor cells and reveal 
endothelial niches for stem cells. Cell 121, 1109-1121. 
Kondoh, H., Lleonart, M.E., Nakashima, Y., Yokode, M., Tanaka, M., Bernard, D., 
Gil, J., and Beach, D. (2007). A high glycolytic flux supports the proliferative 
potential of murine embryonic stem cells. Antioxid Redox Sign 9, 293-299. 
Lutolf, M.P., Doyonnas, R., Havenstrite, K., Koleckar, K., and Blau, H.M. (2009). 
Perturbation of single hematopoietic stem cell fates in artificial niches. Integr Biol 
(Camb) 1, 59-69. 
Nakada, D., Saunders, T.L., and Morrison, S.J. (2010). Lkb1 regulates cell cycle and 
energy metabolism in haematopoietic stem cells. Nature 468, 653-658. 
Chapter 3: Mitochondrial activity and HSC fate 
????
Osawa, M., Hanada, K., Hamada, H., and Nakauchi, H. (1996). Long-term 
lymphohematopoietic reconstitution by a single CD34-low/negative hematopoietic 
stem cell. Science 273, 242-245. 
Parmar, K., Mauch, P., Vergilio, J.A., Sackstein, R., and Down, J.D. (2007). 
Distribution of hematopoietic stem cells in the bone marrow according to regional 
hypoxia. Proc Natl Acad Sci U S A 104, 5431-5436. 
Peters, S.O., Kittler, E.L., Ramshaw, H.S., and Quesenberry, P.J. (1996). Ex vivo 
expansion of murine marrow cells with interleukin-3 (IL-3), IL-6, IL-11, and stem 
cell factor leads to impaired engraftment in irradiated hosts. Blood 87, 30-37. 
Piccoli, C., Ria, R., Scrima, R., Cela, O., D'Aprile, A., Boffoli, D., Falzetti, F., 
Tabilio, A., and Capitanio, N. (2005). Characterization of mitochondrial and extra-
mitochondrial oxygen consuming reactions in human hematopoietic stem cells. Novel 
evidence of the occurrence of NAD(P)H oxidase activity. J Biol Chem 280, 26467-
26476. 
Sahin, E., Colla, S., Liesa, M., Moslehi, J., Muller, F.L., Guo, M., Cooper, M., 
Kotton, D., Fabian, A.J., Walkey, C., et al. (2011). Telomere dysfunction induces 
metabolic and mitochondrial compromise (vol 470, pg 359, 2011). Nature 475. 
Simsek, T., Kocabas, F., Zheng, J., Deberardinis, R.J., Mahmoud, A.I., Olson, E.N., 
Schneider, J.W., Zhang, C.C., and Sadek, H.A. (2010). The distinct metabolic profile 
of hematopoietic stem cells reflects their location in a hypoxic niche. Cell Stem Cell 
7, 380-390. 
Suda, T., Takubo, K., and Semenza, G.L. (2011). Metabolic regulation of 
hematopoietic stem cells in the hypoxic niche. Cell Stem Cell 9, 298-310. 
Takizawa, H., Regoes, R.R., Boddupalli, C.S., Bonhoeffer, S., and Manz, M.G. 
(2011). Dynamic variation in cycling of hematopoietic stem cells in steady state and 
inflammation. J Exp Med 208, 273-284. 
Takubo, K., Nagamatsu, G., Kobayashi, C.I., Nakamura-Ishizu, A., Kobayashi, H., 
Ikeda, E., Goda, N., Rahimi, Y., Johnson, R.S., Soga, T., et al. (2013). Regulation of 
glycolysis by Pdk functions as a metabolic checkpoint for cell cycle quiescence in 
hematopoietic stem cells. Cell Stem Cell 12, 49-61. 
Tothova, Z., Kollipara, R., Huntly, B.J., Lee, B.H., Castrillon, D.H., Cullen, D.E., 
McDowell, E.P., Lazo-Kallanian, S., Williams, I.R., Sears, C., et al. (2007). FoxOs 
are critical mediators of hematopoietic stem cell resistance to physiologic oxidative 
stress. Cell 128, 325-339. 
Wilson, A., Laurenti, E., Oser, G., van der Wath, R.C., Blanco-Bose, W., Jaworski, 
M., Offner, S., Dunant, C.F., Eshkind, L., Bockamp, E., et al. (2008). Hematopoietic 
stem cells reversibly switch from dormancy to self-renewal during homeostasis and 
repair. Cell 135, 1118-1129. 
Yamamoto, R., Morita, Y., Ooehara, J., Hamanaka, S., Onodera, M., Rudolph, K.L., 
Ema, H., and Nakauchi, H. (2013). Clonal Analysis Unveils Self-Renewing Lineage-
Chapter 3: Mitochondrial activity and HSC fate 
? ???
Restricted Progenitors Generated Directly from Hematopoietic Stem Cells. Cell 154, 
1112-1126. 
Yamazaki, S., Iwama, A., Takayanagi, S., Morita, Y., Eto, K., Ema, H., and 
Nakauchi, H. (2006). Cytokine signals modulated via lipid rafts mimic niche signals 
and induce hibernation in hematopoietic stem cells. EMBO J 25, 3515-3523. 
Yu, W.M., Liu, X., Shen, J., Jovanovic, O., Pohl, E.E., Gerson, S.L., Finkel, T., 
Broxmeyer, H.E., and Qu, C.K. (2013). Metabolic Regulation by the Mitochondrial 
Phosphatase PTPMT1 Is Required for Hematopoietic Stem Cell Differentiation. Cell 
Stem Cell 12, 62-74. 
Zhang, C.C., Kaba, M., Ge, G., Xie, K., Tong, W., Hug, C., and Lodish, H.F. (2006). 
Angiopoietin-like proteins stimulate ex vivo expansion of hematopoietic stem cells. 
Nat Med 12, 240-245. 
Zheng, J., Huynh, H., Umikawa, M., Silvany, R., and Zhang, C.C. (2011). 
Angiopoietin-like protein 3 supports the activity of hematopoietic stem cells in the 
bone marrow niche. Blood 117, 470-479. 
 
  
Chapter 3: Mitochondrial activity and HSC fate 
????
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Chapter 4 
Asymmetric HSC divisions 
  
Chapter 4: Asymmetric HSC divisions 
?
????
 
  
Chapter 4: Asymmetric HSC divisions 
? ???
 
 
Identification of asymmetrically expressed genes in paired 
daughter HSCs 
 
 
Manuscript under preparation 
 
 
Mukul Girotra1, Aline Roch1, Matthias P. Lutolf 1 
 
 
 
 
1Laboratory of Stem Cell Bioengineering, Ecole Polytechnique Fédérale de Lausanne 
(EPFL), Lausanne, Switzerland 
 
 
 
Corresponding author 
Prof. Matthias P. Lutolf  
Laboratory of Stem Cell Bioengineering 
Institute of Bioengineering,  
Ecole Polytechnique Fédérale de Lausanne 
CH-1015 Lausanne, Switzerland 
Tel: +41216931876; E-mail: matthias.lutolf@epfl.ch 
  
Chapter 4: Asymmetric HSC divisions 
?
????
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Chapter 4: Asymmetric HSC divisions 
? ???
Abstract 
The maintenance of hematopoietic stem cell (HSC) pool and concomitant production 
of committed daughter cells are critical for the life long production of blood. Under 
homeostasis, HSCs in the native niche are believed to achieve this dual role by 
undergoing a process called asymmetric cell division (ACD), whereby one daughter 
cell maintains stem cell potential while the other differentiates to give rise to various 
blood cell lineages. Since in vitro methods lack critical instructive signals of the in 
vivo niche, it is currently not possible to study self-renewal and ACD in a dish. Here 
we explored the possibility to ‘pre-instruct’ fate in activated HSCs directly in the in 
vivo niche, in order to assess fate choices of dividing HSCs in vitro in a cell-intrinsic 
manner. To this end, we activated HSCs by Interferon-α (IFNa) and analyzed paired 
daughter cells (PDCs) by in vitro tracking of cell division and multi gene expression 
analysis at the single cell level. IFNa treatment was found to significantly increase the 
proportion of asynchronously dividing HSC daughters, indicating a possible 
involvement of asymmetric divisions. Indeed, gene expression analysis of PDC 
revealed a set of 12 asymmetrically expressed genes, among them were, stem cell 
markers such as CD150 and CD34; enzymes such as hexokinase-2 and aconitase-1, 
that are part of key metabolic pathways; Glut-1, a glucose transporter; and, Tie2, a 
recently used asymmetry marker in the HSC field. Activated pairs showed 
significantly higher asymmetry index (A.I) values, a parameter we developed to 
quantitate asymmetry in expression. 
 
Introduction 
A fine balance of different HSC fate choices is indispensable for life long blood 
production. Uncontrolled stem cell expansion or differentiation can be detrimental for 
the survival of the organism. Therefore, asymmetric cell division (ACD) appears to be 
an attractive strategy that allows for both, the maintenance of stem cell number as 
well as the production of differentiated progeny, at the same time (Morrison and 
Kimble, 2006). In mammals, poor accessibility to stem cells and limited 
understanding of niche biology has made it difficult to elucidate ACD. 
 
Classical studies in lower organisms such as Drosophila Melanogaster and C. 
Elegans have shed light on both extrinsic and cell intrinsic mechanisms mediating 
asymmetric cell division in stem cell systems. C. Elegans zygote, which divides 
asymmetrically to produce one large blastomere (taking on an ectoderm fate) and one 
small blastomere (taking on a mesoderm and endoderm fate), is an example of ACD 
where intrinsic mechanisms mediate asymmetry (Doe and Bowerman, 2001). 
Asymmetric localization of partitioning defective (PAR) family of proteins, such as 
PAR-3, PAR-6 and aPKC, govern mitotic spindle orientation and asymmetric 
segregation of key cell fate determinants resulting in ACD of the C.Elegans zygote 
(Mello et al., 1996; Strome and Wood, 1983; Suzuki and Ohno, 2006). Similar 
mechanisms regulate ACD in the Drosophila neuroblast, where Numb, a cell fate 
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determinant, localizes only to the daughter cell that is destined to differentiate (Spana 
et al., 1995). Interestingly, this mechanism was found to be conserved in the 
mammalian system such as in neural progenitors in the developing rodent brain where 
Numb is asymmetrically segregated to precursors destined for neurogenesis (Shen et 
al., 2002; Zhong et al., 1996). Drosophila germ line stem cells provide an interesting 
example where extrinsic mechanisms orchestrate ACD. Correct orientation of division 
ensures that one daughter remains in the stem-cell niche and retains stem cell identity, 
while the other daughter placed away from the niche begins to differentiate 
(Yamashita et al., 2005). Instructive cues from the niche (“cap cell” in the ovary and 
“hub cell” in the testis), lead to activation of BMP (in ovary) or JAK-STAT (in testis) 
signaling, which eventually represses differentiation in the daughter destined to 
maintain stem cell potential (Kiger et al., 2001; Song et al., 2004; Tulina and Matunis, 
2001). 
 
In the adult hematopoietic system, ACD is believed to be the primary mechanism by 
which HSC numbers could be maintained under homeostasis (Congdon and Reya, 
2008). Since adult HSCs are primarily quiescent (Cheshier et al., 1999; Wilson et al., 
2008) it becomes difficult to study the mechanisms controlling their division in the 
native bone marrow. However, PDC analyses have revealed different colony forming 
potential (Giebel et al., 2006; Takano et al., 2004) and in vivo reconstitution ability 
(Ema et al., 2000; Yamamoto et al., 2013) in sister cells, suggesting the occurrence of 
ACD in HSCs. Interestingly, unequal Numb segregation in dividing HSCs and 
therefore asymmetric Notch inhibition was demonstrated using a Notch reporter 
mouse (Wu et al., 2007). Since Notch signaling was earlier shown to be important in 
maintaining HSCs in an undifferentiated state (Duncan et al., 2005), this asymmetric 
inhibition by Numb was believed to mediate ACD (Wu et al., 2007). Moreover, when 
cultured on an osteoblastic cell line, HSCs underwent mostly ACD whereas a generic 
stromal cell line induced mostly symmetric divisions (Wu et al., 2007), pointing to the 
role of niche instructed cues, in addition to intrinsic mechanisms, in controlling HSC 
fate. Additionally, several recent reports have indicated asymmetric segregation of 
various proteins during HSC division but their link to asymmetric cell fate was 
difficult to establish (Beckmann et al., 2007; Nteliopoulos and Gordon, 2012; Ting et 
al., 2012). 
 
To elucidate in vivo niche-mediated mechanisms regulating ACD, here we transiently 
activated HSCs out of their quiescence in the native niche using an acute dose of IFNa 
(Essers et al., 2009). Analysis of single cell proliferation kinetics via time-lapse 
microscopy revealed significant increase in asynchronous divisions upon IFNa 
activation. Using single cell gene expression analyses we identified genes that were 
asymmetrically expressed in PDCs. This asymmetric gene set included HSC markers 
such as CD150 (SLAM) and CD34, in addition to metabolic enzymes involved in 
glycolysis and the TCA cycle. Moreover, IFNa-activated pairs showed higher 
asymmetry in gene expression compared to control pairs. Strikingly, this asymmetry 
negatively correlated with time of 1st division, suggesting in vivo activated HSCs 
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undergo ACD. Flow cytometry analysis of some protein candidates showed that they 
were present at different levels in HSCs and progenitor cells. Collectively, in vivo 
programming of HSC fate by activation of quiescent cells combined with single cell 
gene expression analysis enabled us to shed light on niche-mediated processes 
dictating HSC fate choice. 
 
Experimental methods 
Mice 
Mice were purchased from Charles River Laboratories International and maintained at 
the Center for Studying Living System (CAV) at the EPFL in micro-isolator cages. 
Mice were provided continuously with sterile food, water and bedding. All 
experiments were carried out in accordance with the Swiss law. 
?
In vivo activation of HSCs 
HSCs were activated to exit dormancy by interferon-alpha (IFN-α) treatment 
following published protocols (Essers et al., 2009). Briefly, subcutaneous injections in 
C57Bl/6J mice were carried out with 10,000U of IFN-α (R&D systems) 48 and 24 
hours prior to bone marrow extraction. Control mice were injected with an equivalent 
volume of the vehicle (PBS + 0.1% BSA). 
 
Antibodies 
The following antibodies were used: cKit-PeCy7 (2B8, Biolegend), Sca1-APC (D7, 
Biolegend), CD150-PeCy5 (TC-15-12F12.2, Biolegend), CD48-PB (GM48-1, 
Biolegend), CD34-FITC (RAM34, eBiosciences), SAV-PO (life technologies), HK2-
Alexa647 (bs-3993R, Bioss), Aco1-Alexa647 (bs-9848R, Bioss). A mixture of 
biotinylated mAbs against CD3, CD11b, CD45R/B220, Ly-6G, Ly-6C and TER-119 
was used as lineage depletion cocktail (BD Biosciences). 
 
Microwell array fabrication 
Poly ethylene glycol (PEG) microwells were formed at the bottom of 96-well micro 
plate (BD) or 4-well plate (Nunc) by crosslinking 4arm-PEG-thiol (PEG-SH, 10kDa) 
with 8arm-PEG-vinylsulfones (PEGVS, 10kDa) at 5% w/v. Hydrogel films were 
micropatterned by soft embossing with PDMS (polydimethylsiloxane, VWR) stamps 
for one hour to create an array of microwells. 
 
Flow cytometry and cell sorting  
Flow cytometry analysis of hematopoietic stem and progenitor cells was performed 
on freshly isolated bone marrow (BM) from 8-12 weeks old C57Bl/6J mice. BM was 
extracted from crushed femora, tibia and hip bone. Cell suspension was then filtered 
through a 70μm cell strainer and erythroid cells were eliminated by incubation with 
red blood cells lysis buffer (eBioscences). Lineage-positive cells were removed with a 
magnetic lineage depletion kit (Miltenyi Biotech). Cell suspensions were stained with 
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a panel of specific antibodies for stem and progenitor cells and FACS-sorted on BD 
FACS Aria II. The hematopoietic stem cell (HSC) compartment was identified and 
sorted with the following cell surface phenotype Lin- Ckit+ Sca1+ (LKS) CD150+ 
CD48- CD34-. 
 
HSC culture 
HSC cultures were maintained at 5% CO2 at 37o C in serum free media (Stemline II, 
Sigma) supplemented with 100ng/ml SCF (R&D Systems), 2ng/ml Flt3 ligand (R&D) 
and 0.5% P/S.  
 
Cell cycle analysis 
FACS sorted HSCs were fixed and permeabilized using Cytofix/Cytoperm plus kit 
(BD Biosciences), according to the manufacturer instruction. Cells were then stained 
overnight with Ki67 FITC (BD Biosciences) at 4°C, and 10 minutes with Hoechst 
33342 (Invitrogen).  
?
Single cell proliferation analysis 
Individual cells cultured in microwells were imaged on a Zeiss Axio Observer Z1 
inverted microscope equipped with a motorized stage. An incubation chamber 
maintaining temperature and CO2 levels allowed for live cell imaging. The stage was 
programmed to scan the microwell array surface and acquire images of multiple 
positions every 3 hours. Single cell proliferation kinetics were assessed based on 
time-lapse movies. 
 
Micromanipulation of paired daughter cells for single cell analysis 
Single cells in microwells having undergone one division to give rise to two daughter 
cells were identified after 40 hours in culture. Paired daughter cells were isolated by 
micromanipulation in 20um diameter micro capillaries (Eppendorf). Single cells were 
ejected from the micro capillaries into lysis solution for subsequent single cell PCR. 
 
Selection of candidate genes 
47 candidate genes listed in Table 4.1 were selected for expression analysis in PDCs. 
Some of those genes were identified in a microarray analysis where they were 
differentially expressed in HSCs compared to MPPs (Forsberg et al., 2005), or 
compared to mobilized or leukemic HSCs (Forsberg et al., 2010). These included, key 
cell surface molecules such as Jam3, Tie2, ProCR, and Esam1; intracellular adaptor 
proteins Grb10 and Fhl1; and, cycling dependent kinase inhibitor p57 (Umemoto et 
al., 2005). After a careful review of published work we included, cell cycle genes p21, 
p27, and p130, which were shown to be important in HSC quiescence (Cheng et al., 
2000; Passegue et al., 2005; Zou et al., 2011); HSC maintenance genes b-cat (Perry et 
al., 2011), Pten (Zhang et al., 2006), and Gata3 (Ku et al., 2012); and, important self 
renewal mediators, HoxB4 (Krosl et al., 2003) and c-myc (Satoh et al., 2004; Wilson 
et al., 2004). With recent developments in the field, and our own work (chapter 3), 
strongly implying the role of metabolism in HSC fate choices, we included a variety 
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of metabolic genes for our analysis. These included, a glucose transporter (Glut1), key 
glycolytic enzymes (HK2, PFKFB3, Ldha) (Takubo et al., 2013), enzymes involved 
in TCA cycle (CS, Acyl, Aco1, Suclg1, Mdh2), and some key components of the 
oxidative phosphorylation machinery. Based on recent work that implicated fatty acid 
oxidation as a key to HSC maintenance (Ito et al., 2012), we included two acyl-coA 
dehydrogenases (MCad and Lcad) and an enzyme that facilitates the entry of fatty 
acids into the mitochondria (Cpt1a). With growing amount of information on the 
detrimental effects of ROS on HSC function, we included two key antioxidants 
(SOD2 and Cat) that were shown to be instrumental in keeping ROS levels low in 
HSCs (Takubo et al., 2010; Takubo et al., 2013). 
 
Table 4.1: List of genes tested in single cell multi gene expression analysis 
 
Single cell qRT-PCR 
Micromanipulated single cells were ejected in 0.2ml PCR tubes containing 10μl of 
Lysis solution (9μl single cell lysis solution+ 1μl single cell Dnase I). Cells were 
incubated in the lysis solution at RT for upto 30min followed by addition of 1μl of 
single cell stop solution and incubation at RT for upto 20min. The samples were then 
stored at -20°C. Reverse transcription and pre-amplification were performed 
sequentially on the lysed cell sample using Single Cell-to-Ct Kit (Life Technologies). 
Conditions for reverse transcription were 10min at 25°C, 60min at 42°C, and 5min at 
??????????????? ?????????? ? ??????????????? ??????????
??????????????????? ?????  Glycolysis? HK2?
????????????? ????? ? ? PFKFB3?
? ???? ? ? Glut1?
?????????????????? ?????? ? ? Ldha?
? ?????  TCA cycle? CS?
? ????? ? ? Acly?
???? ??????? ?????? ? ? Aco1?
? ????? ? ? Suclg1?
? ????? ? ? Mdh2?
? ??????  Oxidative Phosphorylation? Cyt-C?
??????????????
?????????
?????? ? ? NDUFA2?
? ?????? ? ? COX2 
(Sdhd)?
? ????? ? ? ATP5g1?
? ?????????? ? ? COX1?
?????????????????????? ????????????? ? ? COX3?
? ????????????? ? ? COX4?
? ?????????????  Mitochondrial biogenesis? Mfn2?
? ??????????????? ? ? Tfam?
? ?????  Antioxidants? SOD2?
??????????????
????????
????? ? ? Catalase?
? ??????  Fatty acid oxidation? MCad?
? ?????? ? ? LCad?
? ?????? ? ? CPT1a?
??????????? ??????? ? ? ?
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42°C. Gene Expression TaqMan Assays (Life Technologies) corresponding to the 
gene set  (Table 4.1) were pooled and diluted at 0.2X in 1X TE buffer pH8.0 for pre-
amplification. Samples were incubated for 10min at 95°C and pre-amplified for 14 
cycles of 15 sec at 95°C and 4 min at 60°C on a thermal cycler. The pre-amplified 
samples were diluted 1:15 in 1X TE buffer pH8.0 and stored at -20°C. Real-time 
quantitative PCR was performed with Gene Expression TaqMan Assays (Life 
Technologies) on a 7900HT system (Applied BioSystems). Conditions for 
amplification were 2 min at 50°C and 10 min at 94.5°C followed by 40 cycles of 5sec 
at 97°C and 1min at 59.7°C. Expression values over the threshold of the machine 
(ct=40) were set to 40. 
 
Marker staining for FACS analysis 
Cells were fixed and permeabilized using Cytofix/Cytoperm plus kit (BD 
Biosciences), according to the manufacturer instruction. Cells were stained with anti 
Aco1-Alexa647 or anti HK2-Alexa647 for 1 hour at 4°C followed by washing with 
PBS before being used for analysis. For Glut1 analysis, live cells were stained with 
anti Glut1-PE for 1 hour at 4°C followed by washing with PBS before being used for 
analysis. 
 
CFSE staining 
Freshly sorted HSCs were incubated for 20 min at 37°C with 1:400 CFSE stock 
solution  (Cayman chemicals; CFSE cell division assay kit). Cells were then pelleted 
and re-suspended in Stemline II (Sigma) containing 10% FBS for 20 min at 37°C. 
Thereafter, the cells were washed twice with Stemline II and put in culture. 
 
Transplantation 
Double congenic (CD45.1/45.2) marker system was used for transplantations. CD45.2 
mice were lethally irradiated (850RAD) and transplanted with donor cells isolated 
from CD45.1 mice and helper cells from CD45.1/45.2 mice. HSCs were isolated from 
IFNa activated and control mice. 100 cells were transplanted together with 2*106 
helper cells. Helper cells were obtained from BM of CD45.1/45.2 mice that were 
depleted for Sca1+ and CD150+ cells using Sca1-PE (E13-161.7, Biolegend) and 
CD150-PE (TC15-12F12.2) antibodies and anti-PE microbeads (Miltenyi Biotech). 
Recipient mice were bled at 4, 8 and 16 weeks post transplant and peripheral blood 
was stained with specific antibodies to determine donor-derived chimerism. 
 
Statistics 
Data was statistically analyzed by student t test, Fisher’s exact test. Spearman’s rank 
correlation coefficient was determined for correlation analysis. 
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Results and Discussion 
In vivo activation of HSCs by IFNa increases asynchronous cell divisions 
We used IFNa treatment to activate HSCs to exit their quiescent state in vivo (Essers 
et al., 2009). To this end, subcutaneous injections of IFNa were performed 48 and 24 
hours prior to HSC isolation, control mice were injected with vehicle (Essers et al., 
2009). HSCs were FACS sorted based on a combination of different cell surface 
markers, Lin-ckit+Sca1+ (LKS) CD150+CD48-CD34- (Kiel et al., 2005; Osawa et 
al., 1996; Wilson et al., 2008) (Figure 4.1A). Freshly isolated HSCs were immediately 
fixed and stained to determine their cell cycle status. IFNa treatment resulted in a 
significant increase in the proportion of cycling HSCs (Ki67+) as compared to 
untreated cells, from 25% to almost 60% (Figure 4.1B).  
 
To assess the proliferation kinetics of freshly isolated IFNa-activated HSCs, we used 
our PEG microwell platform in combination with live cell imaging (Lutolf et al., 
2009; Vannini et al., 2012). This allowed us to measure single cell behavior and 
division dynamics in high throughput over a period of up to five days (Figure 4.1C). 
IFNa-activated HSCs carried out the first division much faster as compared to control 
HSCs (Figure 4.1E). The time until half of the population had divided was around 45 
hours for control and was shortened by approximately 9 hours in IFNa-activated cells 
(Figure 4.1E). Proliferation curves showed similar average expansion over a period of 
five days, with IFNa-activated cells demonstrating faster proliferation in the initial 
phases of the culture due to a shorter time to 1st division (Figure 4.1D,E). This data 
confirms that acute IFNa treatment leads to activation of HSCs. 
?
One key property of HSCs is their slower cycling rates as compared to progenitors 
(Nygren et al., 2006; Orford and Scadden, 2008; Wilson et al., 2008). Therefore, we 
thought an analysis of the proliferation kinetics of the first generation of HSC 
daughters could reveal information on the maintenance of stem cell properties such as 
slower cycling rates. We assessed the difference in time of division of PDC to define 
the synchrony of cell division (ΔT). The two paired daughter cells were defined here 
as asynchronous if ΔT was longer than 6 hours (Figure 4.1F). We observed that the 
fraction of asynchronous divisions was significantly higher in IFNa-activated HSCs as 
compared to control cells (Figure 4.1G). This increase in asynchrony suggested a 
possible increase in asymmetric division where one daughter would retain stem cell 
potential (slowly cycling) whereas the other daughter would undergo commitment 
(fast cycling). Previous work has provided some evidence for the production of two 
non-identical daughter cells with different colony forming and blood reconstitution 
levels in vitro (Ema et al., 2000; Giebel et al., 2006; Takano et al., 2004; Yamamoto 
et al., 2013). 
?
?
?
?
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Figure 4.1: In vivo activation of HSCs by IFNa increases asynchronous cell divisions. (A) Isolation of long 
term HSCs based on commonly used cell surface markers (LKSCD150+CD48-CD34-). (B) Cell cycle analysis 
using Ki67 and Hoechst staining on freshly isolated HSCs from control and IFNa treated mice show a significant 
increase in the cycling fraction (Ki67+) upon IFNa administration. (C) Single cell proliferation kinetics analysis 
using live cell imaging of HSCs in PEG microwells (Lutolf et al., 2009). (D-E) Proliferation kinetics of HSCs 
isolated from control and IFNa administered mice.  The average proliferation over 5 days remains similar in the 
two conditions, with IFNa activated cells carrying out the first division much faster (~9h) as compared to control 
HSCs. (F) Representative example of synchronous division (top) and an asynchronous division (below) with ΔΤ of 
greater than 6 hours being used as a threshold. (G) IFNa activated HSCs show a significant increase in the 
proportion of asynchronous divisions. ***P< 0.001, **P< 0.01 and *P< 0.05 
 
Gene expression analysis in PDCs from IFNa-activated HSCs 
Previous studies have shown that acute activation by IFNa results in HSC self renewal 
(Essers et al., 2009).  As IFNa mediated activation occurs in the native bone marrow 
niche without loss of stem cell potential (Figure 4.7, check appendix, (Essers et al., 
2009)) and in vitro leads to increase in asynchronous divisions (Figure 4.1G), we 
reasoned that this could be a suitable system to study HSC fate choices and 
specifically the process of ACD. To test this, we performed multi gene expression 
analysis in PDCs and compared their gene expression profiles. To this end, we 
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isolated IFNa-activated HSCs from mice and cultured them at single cell level in PEG 
microwells, in basal serum-free culture condition (described in chapter 2), to follow 
their proliferation kinetics (Figure 4.2A). Upon division, PDCs were isolated from the 
microwells by micromanipulation (Figure 4.2B, images by Dr. Aline Roch), and 
analyzed for their gene expression profile using single cell quantitative RT-PCR. 
 
 
 
 
Figure 4.2: Gene expression analysis in PDCs from IFNa-activated HSCs. (A) Freshly isolated HSC were 
cultured in PEG microwells (Lutolf et al., 2009) and allowed to carry out a division. (B) Micromanipulation of 
paired daughter cells (PDCs) generated from a single HSC after one division, for multi gene expression analysis 
(Images by Dr. Aline Roch). 
 
Identification of the asymmetric genes using PDC analysis 
All candidate genes (described in experimental methods) were analyzed in 24 sets of 
PDCs. Strikingly, when Log2(Ct) values of the two cells were plotted against each 
other, different genes showed distinct patterns of expression. Qualitative analysis 
revealed that on one hand, some genes showed extremely symmetric behavior, with 
almost all pairs found close to the diagonal (Figure 4.3A). On the other hand, various 
genes were asymmetrically expressed (Figure 4.3B), with one cell of the pair 
expressing the gene at higher levels (low Ct) and the other at lower levels (high Ct). 
However, for most of these potentially asymmetric genes there remained a sub 
population of pairs that appeared close to the diagonal (Figure 4.3B). 
 
In order to identify asymmetrically expressed genes, we decided to give a quantitative 
value to every gene to determine where it ranked in comparison to the others. To this 
end we obtained the average ΔCt for every gene across all 24 pairs and designated it 
as “Gene score”. 
 
 
?????????? ? ?? ????
???????
???
? ?????????? ???????? ? ???????? ? ????????  
 
A gene score of 1 would indicate an average 2-fold difference in expression in the 
PDCs, and would increment to 4-, 8-, 16- and 32-fold, with gene scores of 2, 3 4 and 
5. We found a huge range of this score with some genes as low as 0.195 (~1.15 fold 
difference), while others as high as 5 (~32 fold difference) (Figure 4.4A). Despite the 
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wide range it appeared to be a gradual curve with no disparate groups (Figure 4.4A). 
Therefore, we decided to put a stringent (although arbitrary) threshold to select out the 
most highly asymmetric genes for further analysis. A cutoff of 10-fold difference was 
applied to identify the asymmetric gene set. A group of 12 genes were identified as 
being above this threshold (Figure 4.4A,B).  
 
 
 
 
Figure 4.3: Qualitative analysis of distribution of gene expression in PDCs. Each gene is shown for the 
expression of 24 pairs of cells, with each dot representing a pair. (A) Representative examples of genes showing 
symmetric expression across most pairs. Most pairs appear close to the “symmetric diagonal” (in red). (B) 
Representative examples of genes showing asymmetric expression in pair daughter cells. Most pairs appearing far 
away from the “symmetric diagonal” (in red). Interestingly most of theses genes had a subpopulation of pairs that 
showed symmetric behavior. 
 
Among the asymmetrically expressed genes, we found some metabolic genes such as 
Glut1, HK2 and Aco1 present in this category (Figure 4.4A-B). Glut-1, a glucose 
transporter across the cell membrane was recently implicated to be important for HSC 
self-renewal in the in vivo niche (Ito and Suda, 2014; Takubo et al., 2013). HK2, a 
glycolytic enzyme involved in the conversion of glucose to glucose-6-phosphate, was 
shown to be upregulated by HIF1a (Mathupala et al., 2001), a key component 
involved in HSC function (Takubo et al., 2013). Aco1, an important TCA cycle 
enzyme in the mitochondria converting citrate to iso-citrate, its asymmetric 
expression fitting well with our previous finding implicating mitochondrial activity as 
a determinant of HSC fate (chapter 3).  Apart from these metabolic genes we also 
found Jam3, p27, and gadd45, genes implicated in HSC function ((Chen et al., 2014; 
Liebermann and Hoffman, 2007; Zou et al., 2011), Roch et al., submitted), to be 
asymmetrically expressed. Interestingly, Tie2 (receptor of Ang-1) was highly 
asymmetric (~22 fold), confirming previous reports of its importance in HSC 
maintenance (Arai et al., 2004) and use as an asymmetry marker (Ito et al., 2012). 
Unexpectedly, we found CD34 to be also asymmetrically expressed in PDCs unlike in 
previously (chapter 2), where almost all cells expressed it once put in culture. This 
difference could be due to the fact HSCs here were activated in their native niche in 
vivo while previous experiments were carried out with un-manipulated cells. 
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Figure 4.4: Identification of the asymmetric genes using PDC analysis. (A) Gene score values (of all 47 
candidates) show a wide variation from gene to gene. A very stringent threshold (average 10-fold difference in 
gene expression between PDCs) was put to identify the “asymmetric gene set”. (B) Table showing 12 candidates 
including some key metabolic genes that were seen to cross the 10-fold threshold (fold change values in table). (C) 
IFNa activated HSCs showed significantly higher values of (A)symmetry index suggesting increase in asymmetric 
divisions in this condition (N=32 for control, N-24 for IFNa). (D-E) Correlation analysis between time to 1st 
division and A.I value revealed that these two variables were negative correlated in both control (D) and in IFNa 
activated cells (E), with IFNa conditions showing higher value of negative correlation (r=-0.3319 for IFNa and -
0.1068 for control). (F-K) Expression of asymmetric genes in various pairs from the IFNa condition. (F-H) 
Representative examples of pairs with high A.I values. Most genes were seen away from the symmetry diagonal 
(in red). (I-K) Representative examples of pairs with low A.I values. Most genes seen very close to the symmetry 
diagonal (in red). ***P< 0.001, **P< 0.01 and *P< 0.05 
Chapter 4: Asymmetric HSC divisions 
?
????
IFNa-activated HSCs show higher asymmetry than control PDCs 
Having identified a set of asymmetrically expressed genes we next checked the 
asymmetry associated in individual pairs linked to this gene set. To obtain a single 
quantitative readout of symmetry for a pair we calculated the Euclidian distance 
between two cells of a pair by summing up the square ΔCt value for all genes in the 
“asymmetric” gene set and calculating its square root. We called this value as the 
(A)symmetry index (A.I) for a pair, with a higher value of A.I reflecting higher 
asymmetric gene expression. 
 
 
?? ? ? ????????????? ?????????????
???????
???
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Pairs with high A.I value (representative examples shown in Figure 4.4F-H) showed 
asymmetric expression of these genes and very often the expression was restricted to 
only one cell of the pair (Figure 4.4F-H). On the contrary, pairs with low A.I value 
(representative examples shown in Figure 4.4I-K) showed most genes being 
expressed symmetrically and were found very close to the diagonal (Figure 4.4I-K). A 
comparative analysis revealed that IFNa-activated pairs had significantly higher value 
of A.I than their control counterparts (Figure 4.4C).  
 
From our previous cell cycle analysis (Figure 4.1B) we saw that IFNa treatment did 
not activate all HSCs, consistent with published data (Essers et al., 2009). 
Approximately 60% of the cells were cycling (Ki67+) while the remaining 40% were 
still in the quiescent state at the time of isolation (Figure 4.1B). We thus hypothesized 
that the activated fraction of cells would divide faster in our cultures and would have 
a higher possibility to carry out the niche-instructed program of asymmetric division, 
whereas cells that were still in the quiescent state at the time of isolation would be 
lacking the in vivo cues and therefore, execute an in vitro program that is niche-
independent, resulting most likely in symmetric commitment divisions. To test this 
hypothesis we checked the correlation between A.I and time to 1st division.  
Intriguingly, we found that A.I and time to 1st division were negatively correlated 
(Figure 4.4D-E), and the extent of this negative correlation was higher in the IFNa 
activated cells (Figure 4.4E). This data supported the idea that HSCs have a higher 
propensity to divide asymmetrically when being instructed in the intact niche. 
 
HSCs and progenitor populations demonstrate differential expression of 
metabolic genes 
Having identified that metabolic genes Glut1, Aco1 and HK2 are asymmetrically 
expressed in PDCs (Figure 4.3), we next assessed the protein expression levels of 
these markers by flow cytometry. To this end, we stained different cell populations in 
the hematopoietic hierarchy with antibodies against these proteins. Strikingly, we 
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found that the most primitive population LT-HSCs (LKS CD150+CD48-CD34-) had 
a higher fraction of Aco1-low cells as compared to the more committed populations 
(ST-HSC: LKS CD150+CD48-CD34+ and MPP: LKS CD150-) (Figure 4.5B). These 
data supports our findings that low mitochondrial activity is a key determinant of 
HSC state (chapter 3). HK2 expression showed an opposite trend, with the fraction of 
HK2-low cells increasing in the MPPs compared to LT-HSCs (Figure 4.5A). This 
supports the notion that HSCs fulfill their energy needs through glycolysis while 
keeping their mitochondrial activity low (Ito and Suda, 2014; Simsek et al., 2010; 
Takubo et al., 2013). Interestingly, Glut1 expression showed a stepwise increase from 
the most primitive population (LT-HSCs) to the most committed population (MPPs) 
(Figure 4.5C). Repetition of this analysis will be carried out to confirm these findings.  
 
Of note, previous flow cytometry analysis performed in the lab had identified three of 
these asymmetric gene candidates (Esam1, Tie2 and Jam3) to be highly expressed in 
LT-HSCs as compared to committed progenitor cells (Figure 4.8, check appendix, 
figure from Dr. Aline Roch’s thesis). The differential expression pattern of these 
candidates in LT-HSCs and progenitors suggested that these genes could be used as 
potential markers to identify asymmetric cell division. 
  
 
 
Figure 4.5: HSCs and progenitor populations demonstrate differential expression of metabolic genes. 
Expression of key metabolic markers identified in figure 4.4 was tested in various populations of the hematopoietic 
hierarchy using flow cytometry. Long term HSCs (LT-HSCs: LKSCD150+CD48-CD34-), short term HSCs (ST-
HSCs: LKSCD150+CD48-CD34+) and multipotent progenitors (MPPs: LKSCD150-) were identified using a 
combination of cell surface markers. Cells were then fixed and stained (for HK2 and Aco1) or directly stained (for 
Glut1) to be analyzed by flow cytometry. (A) HK2 levels in HSCs were observed to be higher in HSCs than in 
MPP (HK2 low population increasing from ~36% to ~52% from LT-HSCs to MPPs). (B) Aco1 levels were 
observed to be low in LT-HSCs (Aco1 low ~25%) and increased in short term HSCs and MPPs (Aco1 low ~11%). 
(C) Glut1 levels changed dramatically from the LT-HSCs (Glut1 low ~61%) to ST-HSCs (Glut1 low ~23%) to 
MPPs (Glut1 low ~2.5%), with concomitant increase as one moves down in the hematopoietic hierarchy. (n=1) 
?
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Figure 4.6: HSCs upon division show distinct expression levels of metabolic asymmetry markers. Divisional 
tracking (by CFSE) was combined with markers analysis to check the expression profile of the metabolic markers 
upon HSC division. (A) CFSE staining was used to identify HSC divisions and cells that underwent precisely one 
division were analyzed for their expression profiles in control and IFNa condition. (B) A large proportion of cells 
with high HK2 levels were seen in both conditions. (C) Aco1 low fraction in the control condition was found to be 
much higher than IFNa. This could be due to overall higher expression of Aco1 in IFNa treated cells (D) Glut1 
staining also showed two distinct populations with different expression levels. (B-D) Since HSC cell number is 
often limiting to see distinct populations we used staining controls (LKS cells) to define low and high gates for our 
markers. (n=1) 
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We next tested whether a proportion of first generation of daughter cells maintains 
these newly identified metabolic stem cell characteristics, a high-HK2, low-Aco1 and 
low-Glut1 (Figure 4.5). Retention of these characteristics in cells post division would 
indicate an occurrence of ACD. To this end, we combined divisional tracking using 
our CFSE assay (described in chapter 2) with staining for the metabolic markers; 
based on the CFSE signal we identified cells that had divided precisely one time 
(Figure 4.6A). In both control and IFNa we found a large proportion of cells showing 
high HK2 levels (Figure 4.6B). Also, a substantial fraction retained the Glut1-low 
characteristic in both control and IFNa derived daughters (Figure 4.6D). Interestingly, 
Aco1-low fraction was found to be reduced in IFNa (17%) as compared to control 
(~57%) (Figure 4.6C). This could result from an overall higher expression of Aco1 in 
HSCs due to IFNa treatment. Since only a fraction of the first generation daughter 
cells retain HSC characteristics, it suggests that some HSCs carried out ACD. 
However, more repeats will be performed to confirm these initial findings 
 
Conclusions 
Here we describe a unique experimental strategy to assess niche-instructed HSC fate 
choices in an in vitro set up. By using acute IFNa treatment we could transiently 
activate HSCs in their native in vivo microenvironment. Strikingly, live single cell 
imaging revealed a significant increase in asynchronous divisions in activated HSCs, 
suggesting the execution of a niche-instructed asymmetric cell division (ACD) 
program. Using single-cell gene expression analysis in paired daughter cells (PDCs) 
we identified a group a 12 asymmetrically expressed genes, including enzymes from 
glycolytic and mitochondrial TCA cycle pathways. Moreover, PDCs arising from 
niche-instructed HSCs demonstrated a significant increase in asymmetry index value, 
a quantitative read out for asymmetric gene expression. Furthermore, preliminary 
flow cytometry analysis indicated that the protein expression of these metabolic 
candidates was different in HSCs compared to the progenitors, suggesting 
maintenance of a unique metabolic state in HSCs.  
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Several attempts to expand HSCs in vitro have failed, primarily due to the lack of 
instructive niche signals in the dish. A complex interplay of niche based signals, and 
intracellular mechanisms, are believed to guide HSC fate choices in vivo (Nakamura-
Ishizu and Suda, 2013; Wang and Wagers, 2011; Wilson and Trumpp, 2006). 
Moreover, the hypoxic nature of the niche (Parmar et al., 2007; Spencer et al., 2014) 
presents an extreme metabolic environment, imposing HSCs to attain a unique 
metabolic identity in comparison to its committed progeny (Ito and Suda, 2014; Suda 
et al., 2011). This thesis has employed innovative experimental strategies to 
investigate a link between metabolism and HSC fate choices. A deeper understanding 
of the metabolic regulation of HSC fate will be crucial in developing novel assays for 
the expansion and identification of HSCs for their use in the clinic. 
 
Divisional tracking of HSCs in vitro 
In the first part of this thesis a cell-tracking strategy was developed to systematically 
follow HSC fates in vitro. Current methods involving PKH dyes only identify, very 
crudely, a fast and a slow cycling population in vitro, without any resolution on the 
precise number of divisions and more importantly, without any relationship to 
immunophenotypes (Lee et al., 2002; Yan et al., 2003). 
 
Using CFSE, a cell permeable dye, we could reliably follow up to five HSC divisions 
in vitro. Moreover, CFSE-based tracking combined with immunostaining allowed 
mapping of the HSC phenotype across different divisional states, in defined culture 
conditions promoting specific HSC fates. Preliminary findings indicate that the self-
renewing condition maintained the highest proportion of cells expressing the HSC 
phenotype, compared to the other conditions. Nevertheless, this difference became 
minimal after the second divisional state, suggesting the importance of the first two 
divisions in maintaining HSC phenotypes in culture. Intriguingly, we found a 
systematic loss of the HSC phenotype with increasing divisions in all conditions, 
supporting the current view in the field of cycling induced stem cell exhaustion 
(Orford and Scadden, 2008). However, functional assays still need to be performed to 
ascertain if this phenotype indeed reports in vivo long-term blood reconstitution 
potential. 
 
This to our knowledge is a first attempt to rigorously characterize HSC phenotypes as 
a function of divisional history in vitro. Moreover, it opens up avenues to test the 
evolution of other stem cell markers in different divisional states. Some examples of 
the widespread use of this assay are reported in chapter 3 and 4 of this thesis, where it 
was successfully combined with different metabolic or intracellular markers.  
 
Mitochondrial metabolism and HSC fate 
There is growing evidence in the field supporting the role of metabolic cues from the 
niche in determining HSC fate in vivo (Ito and Suda, 2014; Suda et al., 2011). As 
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highlighted before, the hypoxic nature of the niche is believed to maintain HSCs in a 
distinct metabolic state (Takubo et al., 2010; Takubo et al., 2013).   
 
In the second part of this thesis, we report a powerful approach of predicting, and 
directing, HSC fate based on mitochondrial metabolism. We found that phenotypic 
HSCs and the progenitor cells vary substantially in their mitochondrial activity 
profiles, suggesting that HSCs are indeed in a distinct metabolic state. Using long-
term in vivo blood reconstitution assays, we showed that functional stem cells were 
restricted only to the low mitochondrial activity subpopulation of phenotypic HSCs, 
indicating a striking functional heterogeneity in phenotypically defined HSCs 
currently used in the field. This finding calls for the inclusion of metabolic readouts, 
such as mitochondrial activity, to the existing cell surface marker repertoire, to isolate 
functional HSCs from the bone marrow. Recent work in the field has implicated some 
mechanisms that facilitate maintenance of low mitochondrial activity in HSCs. For 
example, HIF1a was shown to up regulate key glycolytic enzymes in order to increase 
the glycolytic flux in HSCs. Moreover, low mitochondrial activity was maintained via 
up regulation of PDKs that inhibited PDH mediated conversion of pyruvate to acetyl-
coA, and therefore reducing flux into the TCA cycle (Takubo et al., 2013). 
 
A comparison of the mitochondrial activity of quiescent and cycling HSCs revealed 
overlapping profiles, indicating that distinct metabolic programs are rather indicative 
of fate choice and not per se a hallmark of the quiescent (versus activated) state. This 
particular finding goes against the current view in the field that links low metabolic 
activity to a quiescent cell cycle status (Ito and Suda, 2014; Suda et al., 2011). 
However, recent findings have demonstrated that rapidly dividing embryonic stem 
cells self-renew by maintaining low mitochondrial activity (Kondoh et al., 2007). 
Moreover, reprogramming of fibroblasts to induced pluripotent stem cells state, 
requires a metabolic switch from mitochondrial oxidative phosphorylation to 
glycolysis (Folmes et al., 2011).  On similar lines, we believe, that maintaining this 
metabolic identity is a prerequisite for HSCs undergoing self-renewing divisions. 
Indeed, in vitro divisional tracking experiments (developed in chapter 2) in 
combination with long term in vivo assays, revealed that self-renewing HSCs retain 
low mitochondrial activity, in marked contrast to differentiated cells that show high 
mitochondrial activity.  
 
Moreover, as the current set of cell surface markers have limited reliability for the 
identification of functional HSCs in vitro (Bunting et al., 1999; Dorrell et al., 2000; 
Zhang and Lodish, 2005), this single metabolic read out provides a robust marker for 
prospective isolation of self-renewing HSCs from heterogeneous in vitro cultures. 
However, a thorough functional analysis comparing surface marker expression and 
this metabolic read-out, in cultured HSCs still needs to be undertaken.  
 
Strikingly, we found artificial lowering of mitochondrial activity could induce self-
renewal fate under conditions that normally would induce rapid commitment. 
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Therefore, we believe HSC mitochondrial metabolism is not a mere adaptation to the 
in vivo hypoxic microenvironment but is a determinant of HSC fate. However, 
whether such modulation can be induced in vivo, and its effect on HSC function still 
needs to be ascertained. 
 
Asymmetric HSC divisions 
Amongst the different fate choices that an HSC can undertake in vivo, asymmetric cell 
division (ACD) appears to be the most relevant one under homeostasis (Congdon and 
Reya, 2008; Morrison and Kimble, 2006). The production of one stem and one 
committed daughter cell, allows the organism to maintain stem cell number and give 
rise to various blood cell lineages at the same time. However, absence of niche-based 
instructive signals in vitro, result in rapid commitment of HSCs. Due to this limitation 
it is currently impossible to study self-renewal and ACD in a dish. In the last part of 
this thesis we report a unique experimental strategy to analyze niche-instructed fate 
choices in an in vitro set up. Using acute IFNa treatment (Essers et al., 2009), we 
could transiently activate HSCs from their quiescent state in the native in vivo 
environment. Analysis on cell-cycle properties and gene expression profiles of paired 
daughter cells (PDCs), arising from these activated HSCs provided key insights on 
niche-instructed programs guiding HSC fate. 
 
Live cell imaging revealed a significant increase in asynchronous divisions in 
activated HSCs, suggesting the execution of a niche-instructed ACD program. 
Previous studies in invertebrates have elegantly demonstrated the role of the niche in 
orchestrating ACD. For example, in Drosophila, close association with the niche (cap 
cell in the ovary and hub cell in the testis) is instrumental in the execution of ACD of 
germline stem cells. Instructive cues from the niche lead to the activation of BMP (in 
ovary) or JAK-STAT (in testis) signaling, which eventually represses differentiation 
in the daughter cell destined to maintain stemness (Kiger et al., 2001; Song et al., 
2004; Tulina and Matunis, 2001; Yamashita et al., 2005). PDC analyses in the 
hematopoietic system have revealed, different colony forming potential (Giebel et al., 
2006; Takano et al., 2004) and in vivo reconstitution ability (Ema et al., 2000; 
Yamamoto et al., 2013), in sister cells, suggesting the occurrence of ACD in HSCs. 
However, the precise mechanisms that regulate this fate choice are currently 
unknown. 
 
Gene expression analysis led to the identification of a group of 12 asymmetrically 
expressed genes in on PDCs. Importantly, the three metabolic genes in this group 
belonged to either the glycolytic (HK2, Glut1) or mitochondrial (Aco1) pathways, 
suggesting the role of these metabolic pathways in mediating niche-instructed HSC 
fate choice. Recent studies have implicated hypoxia-inducible factor (HIF1a) in 
promoting glycolytic- and inhibiting mitochondrial-flux in HSCs in vivo (Takubo et 
al., 2013). However, our cultures were carried out under normoxia, where HIF1a is 
actively degraded (Suda et al., 2011). It will be interesting to see the expression of 
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these metabolic genes in HSCs cultured under hypoxic conditions. Additionally, it 
needs to be tested if the expression of these metabolic genes can be regulated by other 
mechanisms in HSCs. Moreover, long-term blood reconstitution assays will be 
necessary to ascertain whether asymmetry in gene expression corresponds to 
asymmetric fate of daughter cells. 
 
Perspective on human HSCs 
The characterization of the human hematopoietic system began fairly recently. With 
the development of xenotransplantation models and robust functional assays, it is now 
possible to study the human hematopoietic hierarchy (Doulatov et al., 2012). 
Engraftment of human cells in severe combined immune deficient (Scid) mice 
allowed for their marker characterization. Surprisingly, a lack of consistency between 
the mouse and human HSC markers was observed; for example, human HSCs express 
FLT3 receptor (Sitnicka et al., 2003) while mouse cells do not, and mouse HSCs 
express CD150 while human cells do not (Larochelle et al., 2011). Although, many 
groups now believe HSCs are enriched in the CD34+ CD38- Thy1+ CD45RA- 
compartment (Baum et al., 1992; Bhatia and McGlave, 1997; Conneally et al., 1997; 
Lansdorp et al., 1990), there are contrasting reports of the existence of a rare CD34- 
population, that is extremely quiescent and harbors stem cell potential (Anjos-Afonso 
et al., 2013).  With this discrepancy in mind it will be useful to check if low 
mitochondrial activity (independent or in addition to these markers) can be used to 
identify functional HSCs from human samples. Moreover, prospective isolation of 
human HSCs based on the mitochondrial activity read-out from heterogeneous in 
vitro cultures could be a boon for their use in the clinic. Furthermore, clinically 
approved mitochondrial modulators could be tested for their capacity to expand 
human HSCs in culture. Additionally, in vivo modulation of HSC mitochondrial 
metabolism, in principle can induce faster blood production and therefore, could 
expedite the recovery of patients post-transplantation. An interesting avenue that still 
remains unexplored is the effect of mitochondrial activity modulation on bone 
marrow niche cells. 
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Figures related to chapter 2 
 
 
Figure 2.6: Unstained control used for gate setting in different channels 
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Figures related to chapter 3 
 
 
 
 
 
 
Figure 3.6: Purity analysis on different sorted populations. Four populations were sorted based on CD34 and 
TMRM staining. Re-sorting of the purified cells clearly shows that they remain exclusively in their respective 
gates, proving that our metabolically defined populations are distinct and stable. 
 
 
 
Figure 3.7: Viability analysis of identified populations. 
The four indicated HSC populations were sorted and cultured in vitro for 24 hours, followed by Propidium Iodide 
(PI) staining to assess cell viability. Flow cytometry analysis shows no difference in the PI negative (viable) 
fraction in the four fractions, ruling out that TMRM staining is related to differences in cell death. 
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Figure 3.8: MitoTracker® Deep Red analysis of different hematopoietic stem and progenitor 
compartments.  Whole bone marrow cells were stained with MitoTracker® (labeling active mitochondria) and 
HSC markers, and then analyzed by flow cytometry. MitoTracker® staining shows a similar step-wise increase in 
intensity from the most primitive to most committed population as already demonstrated for TMRM (Figure 3.1B). 
 
 
 
 
Figure 3.9: Titration of FCCP-mediated uncoupling. Sorted HSCs were cultured in differentiation condition 
with or without (Ctrl) FCCP for 5 days. FCCP was replenished in the culture media every 24 hours. Concentration-
dependent increase in inhibition of mitochondrial activity was seen upon addition of FCCP. 5μM showed lowering 
of mitochondrial activity without affecting cell viability. 
 
 
 
 
 
Figure 3.10: CFSE analysis of cultured HSCs in the presence of the uncoupler FCCP. HSCs were isolated 
from the bone marrow and stained with CFSE followed by a 5-day culture in differentiation condition with or 
without FCCP. CFSE analysis at the end of culture period demonstrated that all cells had undergone several rounds 
of division in both conditions, ruling out the presence of quiescent cells in the two conditions. 
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Figures related to chapter 4 
 
 
 
 
Figure 4.7: IFNa activation does not result in loss of stem cell potential. HSCs isolated from control and IFNa 
treated mice show similar blood reconstitution levels in irradiated recipients. Moreover, reconstitution was 
observed in both lymphoid and myeloid lineage. 
 
 
 
 
 
 
Figure 4.8: Surface expression of Esam1, Tie2 and JamC (same as Jam3) on HSCs and progenitor 
populations. (Figure from Dr. Aline Roch’s thesis). HSCs showed higher expression levels of Esam1, Tie2 and 
Jam3 as compared to progenitor cells. Different populations were identified with the following cell surface 
markers; HSC: LKSCD150+CD48-CD34-, MPP1: LKSCD150+CD48-CD34+, MPP2: LKSCD150+CD48+, 
MPP3: LKSCD150-CD48+ 
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Table 4.2: List of genes tested and their taqman assay IDs 
 
 
 
 
Classification Gene 
name 
Other name Taqman assay ID 
House keeping gene HPRT  Mm00446968_m1 
ECM proteins Tgm2  Mm00436987_m1 
 Bgn  Mm00455918_m1 
Membrane proteins Esam1 Esam Mm00518378_m1 
 Tie2 TEK Mm00443243_m1 
 Jam3 JamC Mm00499214_m1 
HSC markers CD150 SLAMf1 Mm00443316_m1 
 CD48 SLAMf2 Mm00455932_m1 
 CD34  Mm00519283_m1 
 C-kit CD117 Mm00445212_m1 
Intracellular adaptors Grb10  Mm01180443_m1 
 ProCR EPCR Mm00440992_m1 
 Fhl1  Mm03009774_m1 
 b-catenin Cat Mm00483039_m1 
Cell cycle regulators P57  cdkn1c Mm00438170_m1 
 P27 cdkn1b Mm00438168_m1 
 P21 cdkn1a Mm00432448_m1 
 P130  rab3gap Mm00618533_m1 
 Pten  Mm00477208_m1 
Transcription factors Pbx1  Mm01701537_m1 
 Gata3  Mm00484683_m1 
 c-myc  Mm00487803_m1 
 Hoxb4  Mm00657964_m1 
DNA repair Gadd45  Mm00432802_m1 
Glycolysis HK2  Mm00443385_m1 
 PFKFB3  Mm00504650_m1 
 Glut1  Mm00441480_m1 
 Ldha  Mm01612132_g1 
TCA cycle CS  Mm00466043_m1 
 Acly  Mm01302282_m1 
 Aco1  Mm00801417_m1 
 Suclg1  Mm00451244_m1 
 Mdh2  Mm01208232_m1 
Oxidative Phosphorylation Cyt-C  Mm01621048_s1 
 NDUFA2  Mm00477755_g1 
 COX2 Sdhd Mm00546511_m1 
 ATP5g1 ATP synthase Mm02601566_g1 
 COX1 cyt c oxidase subunit I Mm04225243_g1 
 COX3 cyt c oxidase subunit III Mm04225261_g1 
 COX4 cyt c oxidase subunit IV Mm01250094_m1 
Mitochondrial biogenesis Mfn2  Mm00500120_m1 
 Tfam  Mm00447485_m1 
Antioxidants SOD2  Mm01313000_m1 
 Cat  Mm00437992_m1 
Fatty acid oxidation MCad  Mm00431611_m1 
 LCad  Mm00599660_m1 
 CPT1a  Mm01231183_m1 
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